<article article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Transl Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Transl Gastroenterol</journal-id><journal-title-group><journal-title>Clinical and Translational Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2155-384X</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23238266</article-id><article-id pub-id-type="pmc">3391000</article-id><article-id pub-id-type="pii">ctg201211</article-id><article-id pub-id-type="doi">10.1038/ctg.2012.11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Endoscopy</subject></subj-group></article-categories><title-group><article-title>Randomized Trial of Gatorade/Polyethylene Glycol With or Without Bisacodyl and NuLYTELY for Colonoscopy Preparation</article-title><alt-title alt-title-type="running">Gatorade/PEG vs. NuLYTELY</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gerard</surname><given-names>David P</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name><surname>Holden</surname><given-names>John L</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Foster</surname><given-names>Diane B</given-names></name><degrees>BS, PA-C</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Raiser</surname><given-names>Manfred W</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label><institution>Gastroenterology Services, Ltd.</institution>, Downers Grove, Illinois, <country>USA</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label><institution>Gastroenterology Services, Ltd.</institution>, 3825 Highland Avenue, Suite 203, Downers Grove, Illinois 60515, <country>USA</country>. E-mail: <email>DavidPGerard@comcast.net</email></corresp></author-notes><pub-date pub-type="ppub"><month>06</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2012</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>6</month><year>2012</year></pub-date><volume>3</volume><issue>6</issue><fpage>e16</fpage><lpage></lpage><history><date date-type="received"><day>11</day><month>05</month><year>2012</year></date><date date-type="accepted"><day>11</day><month>05</month><year>2012</year></date></history><permissions><copyright-statement>Copyright © 2012 American College of Gastroenterology</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>American College of Gastroenterology</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/</license-p></license></permissions><abstract><sec><title><offsets xml_i="3335" xml_f="3346" txt_i="11" txt_f="22">OBJECTIVES:</offsets></title><p><offsets xml_i="3357" xml_f="3536" txt_i="23" txt_f="202">We assessed the safety, efficacy, and tolerability of a new preparation of Gatorade and polyethylene glycol (PEG) for colonoscopy with or without bisacodyl compared with NuLYTELY.</offsets></p></sec><sec><title><offsets xml_i="3558" xml_f="3566" txt_i="204" txt_f="212">METHODS:</offsets></title><p><offsets xml_i="3577" xml_f="4078" txt_i="213" txt_f="714">We performed an investigator-blinded, placebo-controlled, randomized trial of 64 oz of Gatorade and 306 g of PEG (G/PEG) with or without 10 mg of bisacodyl and NuLYTELY. A total of 600 outpatients consumed their preparation the day before a morning colonoscopy. The primary endpoint was colon cleanliness assessed by the Boston Bowel Preparation Scale (BBPS). Tolerability was assessed using a subject questionnaire, and safety was assessed from a basic metabolic profile drawn before the colonoscopy.</offsets></p></sec><sec><title><offsets xml_i="4100" xml_f="4108" txt_i="716" txt_f="724">RESULTS:</offsets></title><p><offsets xml_i="4119" xml_f="4184" txt_i="725" txt_f="790">Adding bisacodyl to G/PEG caused more abdominal bloating/cramps (</offsets><italic><offsets xml_i="4192" xml_f="4193" txt_i="790" txt_f="791">P</offsets></italic><offsets xml_i="4202" xml_f="4251" txt_i="791" txt_f="837">&lt;0.01) and did not result in a cleaner colon (</offsets><italic><offsets xml_i="4259" xml_f="4260" txt_i="837" txt_f="838">P</offsets></italic><offsets xml_i="4269" xml_f="4405" txt_i="838" txt_f="974">=0.66) compared with G/PEG without bisacodyl. The BBPS scores in both the G/PEG arms and NuLYTELY arm were not significantly different (</offsets><italic><offsets xml_i="4413" xml_f="4414" txt_i="974" txt_f="975">P</offsets></italic><offsets xml_i="4423" xml_f="4536" txt_i="975" txt_f="1088">=0.19). Compared with subjects in the NuLYTELY arm, subjects in the G/PEG without bisacodyl arm had less nausea (</offsets><italic><offsets xml_i="4544" xml_f="4545" txt_i="1088" txt_f="1089">P</offsets></italic><offsets xml_i="4554" xml_f="4575" txt_i="1089" txt_f="1107">&lt;0.04), vomiting (</offsets><italic><offsets xml_i="4583" xml_f="4584" txt_i="1107" txt_f="1108">P</offsets></italic><offsets xml_i="4593" xml_f="4620" txt_i="1108" txt_f="1132">&lt;0.02), abdominal pain (</offsets><italic><offsets xml_i="4628" xml_f="4629" txt_i="1132" txt_f="1133">P</offsets></italic><offsets xml_i="4638" xml_f="4659" txt_i="1133" txt_f="1151">&lt;0.02), bloating (</offsets><italic><offsets xml_i="4667" xml_f="4668" txt_i="1151" txt_f="1152">P</offsets></italic><offsets xml_i="4677" xml_f="4721" txt_i="1152" txt_f="1193">&lt;0.005), difficulty drinking the liquid (</offsets><italic><offsets xml_i="4729" xml_f="4730" txt_i="1193" txt_f="1194">P</offsets></italic><offsets xml_i="4739" xml_f="4806" txt_i="1194" txt_f="1258">&lt;0.0001), and found the overall preparation easier to tolerate (</offsets><italic><offsets xml_i="4814" xml_f="4815" txt_i="1258" txt_f="1259">P</offsets></italic><offsets xml_i="4824" xml_f="4899" txt_i="1259" txt_f="1331">&lt;0.0001). Subjects in the combined G/PEG arms had a lower serum sodium (</offsets><italic><offsets xml_i="4907" xml_f="4908" txt_i="1331" txt_f="1332">P</offsets></italic><offsets xml_i="4917" xml_f="4940" txt_i="1332" txt_f="1352">&lt;0.0007), chloride (</offsets><italic><offsets xml_i="4948" xml_f="4949" txt_i="1352" txt_f="1353">P</offsets></italic><offsets xml_i="4958" xml_f="4979" txt_i="1353" txt_f="1371">&lt;0.007), and BUN (</offsets><italic><offsets xml_i="4987" xml_f="4988" txt_i="1371" txt_f="1372">P</offsets></italic><offsets xml_i="4997" xml_f="5093" txt_i="1372" txt_f="1465">&lt;0.0001) levels than those in the NuLYTELY arm, but this did not cause any clinical symptoms.</offsets></p></sec><sec><title><offsets xml_i="5115" xml_f="5127" txt_i="1467" txt_f="1479">CONCLUSIONS:</offsets></title><p><offsets xml_i="5138" xml_f="5356" txt_i="1480" txt_f="1698">Bisacodyl added to G/PEG for colon lavage caused more side effects and did not result in a cleaner colon. The G/PEG preparations cleansed the colon as well as NuLYTELY, were far better tolerated, and were equally safe.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="5418" xml_f="5430" txt_i="1707" txt_f="1719">INTRODUCTION</offsets></title><p><offsets xml_i="5441" xml_f="5529" txt_i="1720" txt_f="1808">Colon cancer was the second leading cause of cancer death in the United States in 2008 (</offsets><ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/faststat"><offsets xml_i="5604" xml_f="5635" txt_i="1808" txt_f="1839">http://seer.cancer.gov/faststat</offsets></ext-link><offsets xml_i="5646" xml_f="5843" txt_i="1839" txt_f="2036">). Colonoscopy is probably the most effective screening method for colon cancer, but in 2008, only 53.0–58.5% of the US population aged 50–75 years had undergone a colonoscopy in the past 10 years.</offsets><sup><xref ref-type="bibr" rid="bib1"><offsets xml_i="5881" xml_f="5882" txt_i="2036" txt_f="2037">1</offsets></xref></sup><offsets xml_i="5895" xml_f="6028" txt_i="2037" txt_f="2170"> Concern about the bowel preparation was the most common reason cited by people older than age 50 years for not having a colonoscopy.</offsets><sup><xref ref-type="bibr" rid="bib2"><offsets xml_i="6066" xml_f="6067" txt_i="2170" txt_f="2171">2</offsets></xref></sup></p><p><offsets xml_i="6087" xml_f="6231" txt_i="2172" txt_f="2316">Over the past few decades, attempts have been made to improve the tolerability and efficacy of the bowel preparations used for colonoscopy (see </offsets><xref rid="tbl1" ref-type="table"><offsets xml_i="6265" xml_f="6272" txt_i="2316" txt_f="2323">Table 1</offsets></xref><offsets xml_i="6279" xml_f="6281" txt_i="2323" txt_f="2325">).</offsets></p><p><offsets xml_i="6288" xml_f="6360" txt_i="2326" txt_f="2398">Four-liter polyethylene glycol 3,350 and electrolyte solutions (PEG-ELS)</offsets><sup><xref ref-type="bibr" rid="bib3"><offsets xml_i="6398" xml_f="6399" txt_i="2398" txt_f="2399">3</offsets></xref></sup><offsets xml_i="6412" xml_f="6565" txt_i="2399" txt_f="2552"> are not always well tolerated by patients (GoLYTELY, Braintree Laboratories, Braintree, MA, USA; CoLyte, Alaven Pharmaceutical, LLC, Marietta, GA, USA).</offsets><sup><xref ref-type="bibr" rid="bib4"><offsets xml_i="6603" xml_f="6604" txt_i="2552" txt_f="2553">4</offsets></xref></sup><offsets xml_i="6617" xml_f="6663" txt_i="2553" txt_f="2599"> Sulfate-free versions of PEG-ELS (SF-PEG-ELS)</offsets><sup><xref ref-type="bibr" rid="bib5"><offsets xml_i="6701" xml_f="6702" txt_i="2599" txt_f="2600">5</offsets></xref></sup><offsets xml_i="6715" xml_f="6832" txt_i="2600" txt_f="2717"> are only minimally better tolerated by patients (NuLYTELY, Braintree Laboratories; TriLyte, UCB, Brussels, Belgium).</offsets><sup><xref ref-type="bibr" rid="bib4"><offsets xml_i="6870" xml_f="6871" txt_i="2717" txt_f="2718">4</offsets></xref></sup><offsets xml_i="6884" xml_f="6900" txt_i="2718" txt_f="2734"> Safety concerns</offsets><sup><xref ref-type="bibr" rid="bib6"><offsets xml_i="6938" xml_f="6939" txt_i="2734" txt_f="2735">6</offsets></xref><offsets xml_i="6946" xml_f="6948" txt_i="2735" txt_f="2737">, </offsets><xref ref-type="bibr" rid="bib7"><offsets xml_i="6981" xml_f="6982" txt_i="2737" txt_f="2738">7</offsets></xref></sup><offsets xml_i="6995" xml_f="7049" txt_i="2738" txt_f="2792"> have limited the use of sodium phosphate preparations</offsets><sup><xref ref-type="bibr" rid="bib8"><offsets xml_i="7087" xml_f="7088" txt_i="2792" txt_f="2793">8</offsets></xref></sup><offsets xml_i="7101" xml_f="7166" txt_i="2793" txt_f="2858"> (VISICOL and OsmoPrep, Salix Pharmaceuticals, Raleigh, NC, USA).</offsets></p><p><offsets xml_i="7173" xml_f="7398" txt_i="2859" txt_f="3084">Bisacodyl, a poorly absorbed diphenylmethane laxative that stimulates peristalsis, has been used with a 2-liter version of SF-PEG-ELS (HalfLytely, Braintree Laboratories), but there is no evidence that bisacodyl is effective.</offsets><sup><xref ref-type="bibr" rid="bib4"><offsets xml_i="7436" xml_f="7437" txt_i="3084" txt_f="3085">4</offsets></xref></sup></p><p><offsets xml_i="7457" xml_f="7719" txt_i="3086" txt_f="3348">Combinations of PEG (MiraLAX, Merck, Whitehouse Station, NJ, USA) in low ELS (e.g., Gatorade, The Gatorade Company, Chicago, IL, USA) and bisacodyl have been used in an attempt to improve the tolerability of the bowel preparation. Two investigator-blinded trials</offsets><sup><xref ref-type="bibr" rid="bib9"><offsets xml_i="7757" xml_f="7758" txt_i="3348" txt_f="3349">9</offsets></xref><offsets xml_i="7765" xml_f="7767" txt_i="3349" txt_f="3351">, </offsets><xref ref-type="bibr" rid="bib10"><offsets xml_i="7801" xml_f="7803" txt_i="3351" txt_f="3353">10</offsets></xref></sup><offsets xml_i="7816" xml_f="8007" txt_i="3353" txt_f="3544"> of 238–255 g PEG in 64 oz of Gatorade and 10–20 mg bisacodyl compared with a 4-liter PEG-ELS found better quality preparations with the PEG-ELS and only a minimal difference in tolerability.</offsets></p><p><offsets xml_i="8014" xml_f="8336" txt_i="3545" txt_f="3867">Our uncontrolled observations with 238 g of PEG and 64 oz of Gatorade with or without 10–20 mg of bisacodyl were disappointing, with an unacceptably high number of suboptimal colonoscopy preparations, and patients complained that the 306 g of PEG (G/PEG) preparation took longer to start working and kept them up at night.</offsets></p><p><offsets xml_i="8343" xml_f="8769" txt_i="3868" txt_f="4294">We modified our protocol by increasing the PEG to 306 g given the day before the colonoscopy as 51 g at noon and 255 g from 1700 to 2100 h with 64 oz of Gatorade, and eliminated the bisacodyl. Our uncontrolled observations with the modified G/PEG protocol showed the quality of the preparations were similar to those with NuLYTELY. Patients seemed to tolerate the G/PEG preparation better than the commercial PEG preparations.</offsets></p><p><offsets xml_i="8776" xml_f="9091" txt_i="4295" txt_f="4610">The objective of this study was to evaluate the safety, efficacy, and tolerability of a G/PEG preparation with or without 10 mg of bisacodyl compared with a preparation with NuLYTELY (or TriLyte). The study used an investigator-blinded, placebo-controlled, randomized trial format to compare the three preparations.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="9132" xml_f="9139" txt_i="4612" txt_f="4619">METHODS</offsets></title><sec><title><offsets xml_i="9159" xml_f="9185" txt_i="4620" txt_f="4646">Study design and oversight</offsets></title><p><offsets xml_i="9196" xml_f="9298" txt_i="4647" txt_f="4749">The protocol was approved by the Adventist Midwest Region Institutional Review Board (AMH 2010-01-80, </offsets><ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov"><offsets xml_i="9367" xml_f="9385" txt_i="4749" txt_f="4767">ClinicalTrials.gov</offsets></ext-link><offsets xml_i="9396" xml_f="9745" txt_i="4767" txt_f="5116"> NCT01063049). The trial was designed by the authors with no outside input. Adventist Hinsdale Hospital donated 171 basic metabolic profiles (BMPs) and waived the fee for the Institutional Review Board. All other expenses associated with this study were paid for by the authors. Subjects received no financial reward and paid for their preparations.</offsets></p><p><offsets xml_i="9752" xml_f="10962" txt_i="5117" txt_f="6327">The study was an investigator-blinded, placebo-controlled, randomized trial of three bowel preparations as follows: (1) NU: NuLYTELY (or TriLyte) 4-liter (1 gallon) consumed from 1700 to 2100 h the night before the colonoscopy; (2) G/PEG+P: PEG 51 g in 355 ml (12 oz) of any clear liquid and a placebo (two 0.4 mg folic acid tablets) consumed at noon the day before the colonoscopy and PEG 255 g in Gatorade 1,872 ml (half gallon, 64 oz) consumed from 1700 to 2100 h the day before the colonoscopy; and (3) G/PEG+B: PEG 51 g in 355 ml (12 oz) of any clear liquid and bisacodyl (two 5 mg tablets, Major Pharmaceuticals, Livonia, MI, USA) consumed at noon the day before the colonoscopy and PEG 255 g in Gatorade 1,872 ml consumed from 1700 to 2100 h the day before the colonoscopy. Subjects in the Gatorade arms were blinded to the inclusion of bisacodyl or placebo tablets, and were allowed to choose any non-red variety of Gatorade. Subjects were on clear liquids the day before the colonoscopy and instructed to consume nothing by mouth after midnight, except for medications taken in the morning. Subjects were instructed to take Fleets enemas if their stool was not clear on the morning of the colonoscopy.</offsets></p><p><offsets xml_i="10969" xml_f="11090" txt_i="6328" txt_f="6449">Folic acid was chosen as a cost-effective placebo for bisacodyl, because both tablets were about the same color and size.</offsets></p><p><offsets xml_i="11097" xml_f="11398" txt_i="6450" txt_f="6751">Subjects had their colonoscopy performed between February 2010 and February 2011 by one of three gastroenterologists (DG, JH, and MR) with 17 to 34 years of experience. Colonoscopies were scheduled to begin between 0800 h and noon in the gastrointestinal labs at our office or two community hospitals.</offsets></p><p><offsets xml_i="11405" xml_f="11855" txt_i="6752" txt_f="7202">Subjects were outpatients undergoing elective colonoscopy and at least 18 years of age. Exclusion criteria included: (1) allergies or intolerances to any of the study drugs; (2) pregnancy; (3) those who required a multiple-day colon preparation for previous colonoscopies; or (4) those with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, or toxic megacolon. Each subject signed an informed consent document.</offsets></p><p><offsets xml_i="11862" xml_f="12708" txt_i="7203" txt_f="8049">Before the study began, it was determined that a total of 600 subjects would be enrolled with 200 subjects in each of the three bowel preparation arms. Our staffs were trained to screen and recruit all patients who met the inclusion criteria. Approximately 1,000 consecutive patients were invited to participate in the study to recruit the 600 subjects included in this study. The most common reasons patients declined to participate in the study were that they wanted to choose their own bowel preparation, and they did not want to have blood drawn for a BMP. Randomization was performed using a computer-generated random number table in blocks of 30 subjects with 10 of each of the bowel preparation randomly distributed within each block. Each subject received an identical-appearing envelope with bowel-preparation instructions enclosed (see </offsets><xref ref-type="supplementary-material" rid="sup1"><offsets xml_i="12759" xml_f="12807" txt_i="8049" txt_f="8097">Supplementary Information (pages 1 and 2 online)</offsets></xref><offsets xml_i="12814" xml_f="13443" txt_i="8097" txt_f="8726">). The envelopes for the G/PEG arms of the study contained two 5 mg bisacodyl or 0.4 mg folic acid tablets. Subjects were allowed to withdraw from the study until 24 h before their colonoscopy, and were replaced with another randomly selected subject who was given the same bowel-preparation regimen as the subject who withdrew. Beginning the day before the colonoscopy, all subjects were evaluated on an intention-to-treat basis, no matter what bowel preparation they actually used. Subjects could be switched to another bowel-cleaning regimen chosen by the physician on call if they could not tolerate the one assigned to them.</offsets></p><p><offsets xml_i="13450" xml_f="13531" txt_i="8727" txt_f="8808">One author (DF) was responsible for monitoring the data for any adverse outcomes.</offsets></p></sec><sec><title><offsets xml_i="13553" xml_f="13565" txt_i="8810" txt_f="8822">Measurements</offsets></title><p><offsets xml_i="13576" xml_f="13663" txt_i="8823" txt_f="8910">A questionnaire was filled out by each subject immediately before the colonoscopy (see </offsets><xref ref-type="supplementary-material" rid="sup1"><offsets xml_i="13714" xml_f="13755" txt_i="8910" txt_f="8951">Supplementary Information (page 3 online)</offsets></xref><offsets xml_i="13762" xml_f="14927" txt_i="8951" txt_f="10116">). Subjects were asked to rate their symptoms of nausea, vomiting, abdominal cramps/pain, and bloating on a scale of 0 to 3 as follows: 0=none, 1=mild, 2=moderate, and 3=severe. Subjects were asked: if they had any other problems during their preparation; how much of the preparation they drank; if they needed to call the doctor for advice or help; if they needed to change their assigned preparation, because they could not drink it all; if they needed to take any Fleet enemas the morning of the procedure; if they had to wake up in the middle of the night to have a bowel movement; and if they would want to use the same preparation again if they needed a future colonoscopy. Subjects were asked to rate how difficult it was to drink the liquid, and overall, how difficult the preparation was. Both questions were answered on a scale of 0 to 3 as follows: 0=easy, 1=mildly difficult, 2=moderately difficult, and 3=very difficult. Subjects were asked if they had ever had a colonoscopy before, what preparation they consumed previously, and how was the study preparation compared with their previous preparation (i.e., easier, about the same, or more difficult).</offsets></p><p><offsets xml_i="14934" xml_f="15125" txt_i="10117" txt_f="10308">A BMP was obtained before the intravenous line for the colonoscopy was started. Subjects known to have a creatinine ≥1.30 mg/dl had a baseline BMP drawn in the 30 days before the colonoscopy.</offsets></p><p><offsets xml_i="15132" xml_f="15228" txt_i="10309" txt_f="10405">A questionnaire was filled out by the gastroenterologist immediately after the colonoscopy (see </offsets><xref ref-type="supplementary-material" rid="sup1"><offsets xml_i="15279" xml_f="15320" txt_i="10405" txt_f="10446">Supplementary Information (page 4 online)</offsets></xref><offsets xml_i="15327" xml_f="15736" txt_i="10446" txt_f="10855">) rating the cleanliness of the bowel preparation. The questionnaire included the subject's age and race, the site at which the colonoscopy was performed, if the subject had a history of heart failure or renal insufficiency, the indications for the colonoscopy and the findings, if the subject had a previous colon resection, and whether the cecum (or most proximal extent of the remaining colon) was reached.</offsets></p><p><offsets xml_i="15743" xml_f="15856" txt_i="10856" txt_f="10969">The primary endpoint of this study was the cleanliness of the colon on the Boston Bowel Preparation Scale (BBPS),</offsets><sup><xref ref-type="bibr" rid="bib11"><offsets xml_i="15895" xml_f="15897" txt_i="10969" txt_f="10971">11</offsets></xref></sup><offsets xml_i="15910" xml_f="16006" txt_i="10971" txt_f="11067"> and a secondary endpoint was the cleanliness of the colon on the Ottawa Preparation Scale (OPS)</offsets><sup><xref ref-type="bibr" rid="bib12"><offsets xml_i="16045" xml_f="16047" txt_i="11067" txt_f="11069">12</offsets></xref></sup><offsets xml_i="16060" xml_f="16131" txt_i="11069" txt_f="11140"> as reported by the gastroenterologist performing the colonoscopy (see </offsets><xref rid="tbl2" ref-type="table"><offsets xml_i="16165" xml_f="16172" txt_i="11140" txt_f="11147">Table 2</offsets></xref><offsets xml_i="16179" xml_f="16181" txt_i="11147" txt_f="11149">).</offsets></p><p><offsets xml_i="16188" xml_f="16494" txt_i="11150" txt_f="11456">For both bowel-preparation scales, any segment of the colon that had been completely resected or could not be reached due to difficulty advancing the colonoscope was not rated. Any segment that could not be reached due to more distal segments being poorly prepared was given the worst rating on each scale.</offsets></p><p><offsets xml_i="16501" xml_f="16796" txt_i="11457" txt_f="11752">A secondary endpoint of the study was the cleanliness of the colon as rated by the gastroenterologist. A good-quality colonoscopy was defined as being able to see at least 95% of the mucosa of the visualized colon after washing and suctioning; otherwise, the preparation was rated as inadequate.</offsets></p><p><offsets xml_i="16803" xml_f="16882" txt_i="11753" txt_f="11832">Before the study began, each participating gastroenterologist watched a video (</offsets><ext-link ext-link-type="uri" xlink:href="http://media.bmc.org/Media/BostonBowelPreparationScale.wmv"><offsets xml_i="16984" xml_f="17035" txt_i="11832" txt_f="11883">media.bmc.org/Media/BostonBowelPreparationScale.wmv</offsets></ext-link><offsets xml_i="17046" xml_f="17195" txt_i="11883" txt_f="12032">) as a calibration exercise for both the BBPS and OPS. During the study, any segments that proved difficult to rate were discussed among the authors.</offsets></p></sec><sec><title><offsets xml_i="17217" xml_f="17230" txt_i="12034" txt_f="12047">Data analysis</offsets></title><p><offsets xml_i="17241" xml_f="17292" txt_i="12048" txt_f="12099">Continuous variables were compared using Student's </offsets><italic><offsets xml_i="17300" xml_f="17301" txt_i="12099" txt_f="12100">t</offsets></italic><offsets xml_i="17310" xml_f="17390" txt_i="12100" txt_f="12180">-test (unpaired, two-tailed). Categoric variables were compared using Pearson's </offsets><italic><offsets xml_i="17398" xml_f="17399" txt_i="12180" txt_f="12181">χ</offsets></italic><sup><offsets xml_i="17413" xml_f="17414" txt_i="12181" txt_f="12182">2</offsets></sup><offsets xml_i="17420" xml_f="17537" txt_i="12182" txt_f="12299">-test (non-directional); however, when the observed frequencies were low, Fisher's exact test (two-tailed) was used. </offsets><italic><offsets xml_i="17545" xml_f="17546" txt_i="12299" txt_f="12300">P</offsets></italic><offsets xml_i="17555" xml_f="17624" txt_i="12300" txt_f="12369">-values of less than 0.05 were regarded as statistically significant.</offsets></p><p><offsets xml_i="17631" xml_f="17921" txt_i="12370" txt_f="12660">When this study was designed, no studies using the BBPS had been published. Therefore, we based our sample size on prior studies of preparation quality and tolerability, and estimated that 600 patients (200 per arm) would have the power to detect statistically meaningful differences. In a </offsets><italic><offsets xml_i="17929" xml_f="17937" txt_i="12660" txt_f="12668">post-hoc</offsets></italic><offsets xml_i="17946" xml_f="18185" txt_i="12668" txt_f="12907"> analysis with a sample size of 200 subjects per arm, the probability was 80% that the study would detect a difference between two arms at a two-sided 0.05 significance level, if the true difference between the BBPS of those arms was 0.28.</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="18232" xml_f="18239" txt_i="12910" txt_f="12917">RESULTS</offsets></title><sec><title><offsets xml_i="18259" xml_f="18291" txt_i="12918" txt_f="12950">Subjects and endoscopic findings</offsets></title><p><offsets xml_i="18302" xml_f="18436" txt_i="12951" txt_f="13085">The baseline characteristics of the 200 subjects in each of the three arms of the study were generally well balanced and are shown in </offsets><xref rid="tbl3" ref-type="table"><offsets xml_i="18470" xml_f="18477" txt_i="13085" txt_f="13092">Table 3</offsets></xref><offsets xml_i="18484" xml_f="18575" txt_i="13092" txt_f="13183">. Six indications or findings were significantly more common in one arm than the other arm.</offsets></p><p><offsets xml_i="18582" xml_f="19119" txt_i="13184" txt_f="13721">A total of 36 subjects (15 NU, 9 G/PEG+P, 12 G/PEG+B) withdrew at least 24 h before their scheduled colonoscopy and were replaced; 3 subjects (1 NU, 1 G/PEG+P, 1 G/PEG+B) decided not to undergo a colonoscopy; 14 subjects (3 NU, 4 G/PEG+P, 7 G/PEG+B) postponed their colonoscopy beyond February 2011; 5 subjects (4 NU, 1 G/PEG+B) wanted a different preparation than they were randomly assigned; 5 subjects (3 NU, 2 G/PEG+P) did not want to have their blood drawn; and 9 subjects (4 NU, 2 G/PEG+P, 3 G/PEG+B) withdrew for unstated reasons.</offsets></p><p><offsets xml_i="19126" xml_f="19216" txt_i="13722" txt_f="13812">A post-polypectomy bleed in one subject (1 G/PEG+P) was the only significant complication.</offsets></p><p><offsets xml_i="19223" xml_f="19443" txt_i="13813" txt_f="14033">Colon polyps (including two colon cancers) were found in 102 of 196 (52.0%) average-risk subjects undergoing a screening colonoscopy. Colon polyps (including four colon cancers) were found in 203 of 404 subjects (50.2%, </offsets><italic><offsets xml_i="19451" xml_f="19452" txt_i="14033" txt_f="14034">P</offsets></italic><offsets xml_i="19461" xml_f="19558" txt_i="14034" txt_f="14131">=0.68 vs. average risk subjects) undergoing colonoscopy due to increased risk or active symptoms.</offsets></p><p><offsets xml_i="19565" xml_f="19926" txt_i="14132" txt_f="14493">The cecum (or most proximal extent of the remaining colon) was reached in 593 of 600 (98.8%) subjects. Of the seven incomplete colonoscopies, six (3 NU, 1 G/PEG+P, 2 G/PEG+B) were technically difficult, and one (1 G/PEG+B) had an obstructing sigmoid cancer. There was not a single subject in whom the cecum could not be reached due to an inadequate preparation.</offsets></p></sec><sec><title><offsets xml_i="19948" xml_f="19990" txt_i="14495" txt_f="14537">Preparation quality and laboratory changes</offsets></title><p><offsets xml_i="20001" xml_f="20048" txt_i="14538" txt_f="14585">The cleanliness data for each arm are shown in </offsets><xref rid="tbl4" ref-type="table"><offsets xml_i="20082" xml_f="20089" txt_i="14585" txt_f="14592">Table 4</offsets></xref><offsets xml_i="20096" xml_f="20097" txt_i="14592" txt_f="14593">.</offsets></p><p><offsets xml_i="20104" xml_f="20150" txt_i="14594" txt_f="14640">The laboratory data for each arm are shown in </offsets><xref rid="tbl5" ref-type="table"><offsets xml_i="20184" xml_f="20191" txt_i="14640" txt_f="14647">Table 5</offsets></xref><offsets xml_i="20198" xml_f="20199" txt_i="14647" txt_f="14648">.</offsets></p><p><offsets xml_i="20206" xml_f="20561" txt_i="14649" txt_f="15004">A total of 10 subjects (5 NU, 3 G/PEG+P, 2 G/PEG+B) declined to have their blood drawn, or the nurses forgot to draw their blood on the day of colonoscopy. Another 14 subjects (6 NU, 5 G/PEG+P, 3 G/PEG+B) had hemolyzed samples, making the potassium result unusable. One subject's blood (1 NU) was so hemolyzed that all the values in the BMP were unusable.</offsets></p><p><offsets xml_i="20568" xml_f="20923" txt_i="15005" txt_f="15360">Three subjects, all with no known pre-existing renal disease, had post-preparation serum sodium levels ≤130 mmol/l (1 NU=129 mmol/l; 2 G/PEG+P=120 and 129 mmol/l), and none had any obvious clinical symptoms. The subject who had a serum sodium level of 120 mmol/l had a baseline serum sodium level of 131 mmol/l (drawn for reasons unrelated to this study).</offsets></p><p><offsets xml_i="20930" xml_f="21141" txt_i="15361" txt_f="15569">Two subjects, both with no known pre-existing renal disease, had post-preparation serum potassium levels &lt;3.0 mmol/l (1 G/PEG+P=2.6 mmol/l, 1 G/PEG+B=2.9 mmol/l) and neither had any obvious clinical symptoms.</offsets></p><p><offsets xml_i="21148" xml_f="21313" txt_i="15570" txt_f="15735">One subject with no known pre-existing renal disease had a post-preparation serum creatinine ≥1.50 mg/dl (1 G/PEG+B=1.57 mg/dl) and had no obvious clinical symptoms.</offsets></p><p><offsets xml_i="21320" xml_f="21410" txt_i="15736" txt_f="15826">In the NU arm, the BBPS for subjects consuming 33–75% of their preparation was 7.27±1.81 (</offsets><italic><offsets xml_i="21418" xml_f="21419" txt_i="15826" txt_f="15827">n</offsets></italic><offsets xml_i="21428" xml_f="21497" txt_i="15827" txt_f="15896">=31), for those consuming 76–99% of their preparation was 8.13±1.56 (</offsets><italic><offsets xml_i="21505" xml_f="21506" txt_i="15896" txt_f="15897">n</offsets></italic><offsets xml_i="21515" xml_f="21582" txt_i="15897" txt_f="15964">=32), for those consuming 100% of their preparation was 7.93±1.45 (</offsets><italic><offsets xml_i="21590" xml_f="21591" txt_i="15964" txt_f="15965">n</offsets></italic><offsets xml_i="21600" xml_f="21606" txt_i="15965" txt_f="15971">=137, </offsets><italic><offsets xml_i="21614" xml_f="21615" txt_i="15971" txt_f="15972">P</offsets></italic><offsets xml_i="21624" xml_f="21714" txt_i="15972" txt_f="16059">&lt;0.04 vs. 33–75%), and for those consuming 76–100% of their preparation was 7.97±1.48 (</offsets><italic><offsets xml_i="21722" xml_f="21723" txt_i="16059" txt_f="16060">n</offsets></italic><offsets xml_i="21732" xml_f="21738" txt_i="16060" txt_f="16066">=168, </offsets><italic><offsets xml_i="21746" xml_f="21747" txt_i="16066" txt_f="16067">P</offsets></italic><offsets xml_i="21756" xml_f="21777" txt_i="16067" txt_f="16085">&lt;0.03 vs. 33–75%).</offsets></p><p><offsets xml_i="21784" xml_f="21902" txt_i="16086" txt_f="16204">In all three arms combined, the BBPS for subjects scheduled to undergo colonoscopy from 0800 to 0900 h was 8.02±1.47 (</offsets><italic><offsets xml_i="21910" xml_f="21911" txt_i="16204" txt_f="16205">n</offsets></italic><offsets xml_i="21920" xml_f="21962" txt_i="16205" txt_f="16247">=130), from 0915 to 1000 h was 7.99±1.41 (</offsets><italic><offsets xml_i="21970" xml_f="21971" txt_i="16247" txt_f="16248">n</offsets></italic><offsets xml_i="21980" xml_f="22022" txt_i="16248" txt_f="16290">=209), from 1015 to 1100 h was 7.96±1.25 (</offsets><italic><offsets xml_i="22030" xml_f="22031" txt_i="16290" txt_f="16291">n</offsets></italic><offsets xml_i="22040" xml_f="22086" txt_i="16291" txt_f="16337">=170), and from 1115 to 1200 h was 7.82±1.63 (</offsets><italic><offsets xml_i="22094" xml_f="22095" txt_i="16337" txt_f="16338">n</offsets></italic><offsets xml_i="22104" xml_f="22109" txt_i="16338" txt_f="16343">=91, </offsets><italic><offsets xml_i="22117" xml_f="22118" txt_i="16343" txt_f="16344">P</offsets></italic><offsets xml_i="22127" xml_f="22153" txt_i="16344" txt_f="16370">=0.34 vs. 0800 to 0900 h).</offsets></p><p><offsets xml_i="22160" xml_f="22240" txt_i="16371" txt_f="16451">The correlation coefficient between the total BBPS and the total OPS was −0.796.</offsets></p><p><offsets xml_i="22247" xml_f="22675" txt_i="16452" txt_f="16880">In all three arms combined (when all three colon segments were rated), inadequate preparations were found in 8 of 8 (100%) subjects with BBPS ≤3, 7 of 8 subjects (87.5%) with BBPS=4, 10 of 17 subjects (58.8%) with BBPS=5, 1 of 64 subjects (1.6% colon segments: right=1, transverse=3, left=2) with BBPS=6, 1 of 70 subjects (1.4% colon segments: right=1, transverse=3, left=3) with BBPS=7, and 0 of 425 subjects (0%) with BBPS ≥8.</offsets></p></sec><sec><title><offsets xml_i="22697" xml_f="22730" txt_i="16882" txt_f="16915">Preparation tolerance by subjects</offsets></title><p><offsets xml_i="22741" xml_f="22806" txt_i="16916" txt_f="16981">The data from the subject questionnaire for each arm is shown in </offsets><xref rid="tbl6" ref-type="table"><offsets xml_i="22840" xml_f="22847" txt_i="16981" txt_f="16988">Table 6</offsets></xref><offsets xml_i="22854" xml_f="22855" txt_i="16988" txt_f="16989">.</offsets></p><p><offsets xml_i="22862" xml_f="23107" txt_i="16990" txt_f="17235">Only three subjects (3 NU) could not consume more than 50% of their preparation and were switched to G/PEG. All three were counted, on an intention-to-treat basis, in the NU arm: two had BBPS=9 and one had a BBPS=3 and an inadequate preparation.</offsets></p></sec></sec><sec sec-type="discussion"><title><offsets xml_i="23157" xml_f="23167" txt_i="17238" txt_f="17248">DISCUSSION</offsets></title><p><offsets xml_i="23178" xml_f="23606" txt_i="17249" txt_f="17677">Our investigator-blinded study found no statistically significant differences in the BBPS among the three preparation arms. There was no statistically significant difference between the BBPS of the G/PEG arms combined, and the NU arm, or in the OPS (a secondary endpoint of our study) among the three arms. This is the first randomized trial to show that Gatorade/PEG can be as effective in cleansing the colon as a 4-l PEG-ELS.</offsets></p><p><offsets xml_i="23613" xml_f="24103" txt_i="17678" txt_f="18168">Only 27 subjects (4.5%) had colon preparations that were rated as inadequate for a good quality colonoscopy by the gastroenterologist. There was no statistically significant difference between the number of inadequate preparations in the G/PEG arms combined and the NU arm. If the three patients who were unable to tolerate the NuLYTELY were included with the inadequate preparations, the difference between the G/PEG arms combined and the NU arm would remain not statistically significant.</offsets></p><p><offsets xml_i="24110" xml_f="24341" txt_i="18169" txt_f="18400">Subjects in the G/PEG+B arm had a statistically significant increase in abdominal cramps/pain compared with those in the G/PEG+P arm, but overall, did not find the preparation more difficult. One previous investigator-blinded study</offsets><sup><xref ref-type="bibr" rid="bib10"><offsets xml_i="24380" xml_f="24382" txt_i="18400" txt_f="18402">10</offsets></xref></sup><offsets xml_i="24395" xml_f="24540" txt_i="18402" txt_f="18547"> had compared a 255-g version of G/PEG with and without 10 mg of bisacodyl, and found no significant difference in the OPS between the two arms (</offsets><italic><offsets xml_i="24548" xml_f="24549" txt_i="18547" txt_f="18548">P</offsets></italic><offsets xml_i="24558" xml_f="24579" txt_i="18548" txt_f="18569">-value not reported).</offsets></p><p><offsets xml_i="24586" xml_f="24593" txt_i="18570" txt_f="18577">A study</offsets><sup><xref ref-type="bibr" rid="bib13"><offsets xml_i="24632" xml_f="24634" txt_i="18577" txt_f="18579">13</offsets></xref></sup><offsets xml_i="24647" xml_f="24844" txt_i="18579" txt_f="18776"> of 45 subjects compared the colon cleanliness after a 4-liter PEG-ELS solution with and without 10 mg of bisacodyl, and concluded that there was no significant difference between the arms. A study</offsets><sup><xref ref-type="bibr" rid="bib14"><offsets xml_i="24883" xml_f="24885" txt_i="18776" txt_f="18778">14</offsets></xref></sup><offsets xml_i="24898" xml_f="25411" txt_i="18778" txt_f="19291"> with 442 subjects compared versions of HalfLytely (2 lSF-PEG-ELS) with 10 and 20 mg of bisacodyl and found no difference in colon cleanliness, but fewer side effects were seen with the 10-mg version. An unpublished study with 308 subjects described in the HalfLytely package insert compared versions of the HalfLytely with 5 and 10 mg of bisacodyl, and found no difference in colon cleanliness. There are no published studies that show that bisacodyl is effective as part of a modern colon-cleansing preparation.</offsets><sup><xref ref-type="bibr" rid="bib4"><offsets xml_i="25449" xml_f="25450" txt_i="19291" txt_f="19292">4</offsets></xref></sup></p><p><offsets xml_i="25470" xml_f="26201" txt_i="19293" txt_f="20024">Using low-ELS, such as Gatorade, as part of a preparation for colonoscopy could cause renal injury or electrolyte shifts to occur from the large quantity of PEG and water consumed. Subjects with no known pre-existing renal disease in both G/PEG arms combined had statistically significant lower serum sodium, lower serum chloride, lower serum BUN, and higher serum calcium levels compared with similar subjects in the NU arm. No significant differences in the serum creatinine or potassium levels were noted among the three preparation arms. Although the electrolyte differences were statistically significant, the absolute differences between arms were small and not associated with any clinical symptoms. The two previous studies</offsets><sup><xref ref-type="bibr" rid="bib9"><offsets xml_i="26239" xml_f="26240" txt_i="20024" txt_f="20025">9</offsets></xref><offsets xml_i="26247" xml_f="26249" txt_i="20025" txt_f="20027">, </offsets><xref ref-type="bibr" rid="bib10"><offsets xml_i="26283" xml_f="26285" txt_i="20027" txt_f="20029">10</offsets></xref></sup><offsets xml_i="26298" xml_f="26390" txt_i="20029" txt_f="20121"> comparing G/PEG preparations with GoLYTELY did not measure the subject's serum chemistries.</offsets></p><p><offsets xml_i="26397" xml_f="26566" txt_i="20122" txt_f="20291">As baseline BMPs were not drawn in subjects with no known pre-existing renal disease, it is impossible to know how much their serum chemistries changed. Previous studies</offsets><sup><xref ref-type="bibr" rid="bib5"><offsets xml_i="26604" xml_f="26605" txt_i="20291" txt_f="20292">5</offsets></xref><offsets xml_i="26612" xml_f="26614" txt_i="20292" txt_f="20294">, </offsets><xref ref-type="bibr" rid="bib15"><offsets xml_i="26648" xml_f="26650" txt_i="20294" txt_f="20296">15</offsets></xref><offsets xml_i="26657" xml_f="26659" txt_i="20296" txt_f="20298">, </offsets><xref ref-type="bibr" rid="bib16"><offsets xml_i="26693" xml_f="26695" txt_i="20298" txt_f="20300">16</offsets></xref></sup><offsets xml_i="26708" xml_f="27026" txt_i="20300" txt_f="20618"> with NuLYTELY found small and inconsistent changes in serum chemistries after a preparation with NuLYTELY. In this study, the differences in serum chemistries between subjects in the NU arm and G/PEG arms combined were small, suggesting that the changes in serum chemistries after a G/PEG preparation were also small.</offsets></p><p><offsets xml_i="27033" xml_f="27055" txt_i="20619" txt_f="20641">There is a case report</offsets><sup><xref ref-type="bibr" rid="bib17"><offsets xml_i="27094" xml_f="27096" txt_i="20641" txt_f="20643">17</offsets></xref></sup><offsets xml_i="27109" xml_f="27290" txt_i="20643" txt_f="20824"> of a 73-year-old woman who developed a seizure and was found to have a serum sodium level of 117 mmol/l following a preparation with 64 oz of Gatorade and 255 g of PEG. An abstract</offsets><sup><xref ref-type="bibr" rid="bib18"><offsets xml_i="27329" xml_f="27331" txt_i="20824" txt_f="20826">18</offsets></xref></sup><offsets xml_i="27344" xml_f="27549" txt_i="20826" txt_f="21031"> reported 14 patients with severe hyponatremia, following preparations with G/PEG. Our G/PEG has not been widely used, and studies with large numbers of subjects using this preparation would be reassuring.</offsets></p><p><offsets xml_i="27556" xml_f="27894" txt_i="21032" txt_f="21367">In the 21 subjects with a baseline creatinine ≥1.30 mg/dl, who had both a baseline and pre-colonoscopy BMP drawn, no significant changes in serum chemistries were noted among the three preparation arms. The number of subjects with pre-existing renal disease was small and no subject with a creatinine &gt;2.45 mg/dl enrolled in our study.</offsets></p><p><offsets xml_i="27901" xml_f="29008" txt_i="21368" txt_f="22475">Subjects in the G/PEG arms tolerated their preparations far better than subjects in the NU arm by almost every measure used in this study. Compared with subjects in the NU arm, subjects in the G/PEG+P arm had statistically significantly less nausea, vomiting, abdominal cramps/pain, and bloating. Compared with subjects in the NU arm, subjects in both G/PEG arms combined had statistically significantly less difficulty drinking the liquid, found the overall preparation easier to tolerate, were able to consume 100% of the preparation more frequently, and were more willing to use the same preparation again for a future colonoscopy. Of the subjects who had used any 4-liter PEG preparation for their previous colonoscopy, more subjects found the preparations in the G/PEG arms combined easier to consume than the preparation in the NU arm. These findings were not only statistically significant, but in absolute terms, the differences were quite large. These findings are clinically important, as the consumption of the bowel preparation is the most commonly cited reason for not undergoing a colonoscopy.</offsets><sup><xref ref-type="bibr" rid="bib2"><offsets xml_i="29046" xml_f="29047" txt_i="22475" txt_f="22476">2</offsets></xref></sup></p><p><offsets xml_i="29067" xml_f="29200" txt_i="22477" txt_f="22610">Compared with subjects in the NU arm, subjects in both G/PEG arms combined more frequently woke up at night to have a bowel movement.</offsets></p><p><offsets xml_i="29207" xml_f="29464" txt_i="22611" txt_f="22868">Our 306 g version of G/PEG used a non-traditional split dose with 51 g of PEG at noon the day before the colonoscopy, which may have reduced the side effects compared with NuLYTELY, and accounted for the superior cleansing results compared with other trials</offsets><sup><xref ref-type="bibr" rid="bib9"><offsets xml_i="29502" xml_f="29503" txt_i="22868" txt_f="22869">9</offsets></xref><offsets xml_i="29510" xml_f="29512" txt_i="22869" txt_f="22871">, </offsets><xref ref-type="bibr" rid="bib10"><offsets xml_i="29546" xml_f="29548" txt_i="22871" txt_f="22873">10</offsets></xref></sup><offsets xml_i="29561" xml_f="29642" txt_i="22873" txt_f="22954"> with G/PEG. Our G/PEG had 51 to 68 g more PEG compared with other G/PEG studies,</offsets><sup><xref ref-type="bibr" rid="bib9"><offsets xml_i="29680" xml_f="29681" txt_i="22954" txt_f="22955">9</offsets></xref><offsets xml_i="29688" xml_f="29690" txt_i="22955" txt_f="22957">, </offsets><xref ref-type="bibr" rid="bib10"><offsets xml_i="29724" xml_f="29726" txt_i="22957" txt_f="22959">10</offsets></xref></sup><offsets xml_i="29739" xml_f="30039" txt_i="22959" txt_f="23259"> which might have cleansed the colon better. The Fleets enemas given to subjects whose stools were not clear on the morning of the colonoscopy may have salvaged some preparations, which otherwise would have been inadequate. SF-PEG ELS (NuLYTELY) is better tolerated than sulfate-containing solutions,</offsets><sup><xref ref-type="bibr" rid="bib4"><offsets xml_i="30077" xml_f="30078" txt_i="23259" txt_f="23260">4</offsets></xref></sup><offsets xml_i="30091" xml_f="30160" txt_i="23260" txt_f="23329"> such as GoLYTELY, making our findings even more clinically relevant.</offsets></p><p><offsets xml_i="30167" xml_f="30218" txt_i="23330" txt_f="23381">The American College of Gastroenterology recommends</offsets><sup><xref ref-type="bibr" rid="bib19"><offsets xml_i="30257" xml_f="30259" txt_i="23381" txt_f="23383">19</offsets></xref></sup><offsets xml_i="30272" xml_f="30309" txt_i="23383" txt_f="23420"> that bowel preparations be given as </offsets><sc><offsets xml_i="30313" xml_f="30315" txt_i="23420" txt_f="23422">PM</offsets></sc><offsets xml_i="30320" xml_f="30321" txt_i="23422" txt_f="23423">/</offsets><sc><offsets xml_i="30325" xml_f="30327" txt_i="23423" txt_f="23425">AM</offsets></sc><offsets xml_i="30332" xml_f="30357" txt_i="23425" txt_f="23450"> split doses. Two studies</offsets><sup><xref ref-type="bibr" rid="bib20"><offsets xml_i="30396" xml_f="30398" txt_i="23450" txt_f="23452">20</offsets></xref><offsets xml_i="30405" xml_f="30407" txt_i="23452" txt_f="23454">, </offsets><xref ref-type="bibr" rid="bib21"><offsets xml_i="30441" xml_f="30443" txt_i="23454" txt_f="23456">21</offsets></xref></sup><offsets xml_i="30456" xml_f="30535" txt_i="23456" txt_f="23535"> have compared the day before dosing of a 4-liter PEG-ELS preparation with the </offsets><sc><offsets xml_i="30539" xml_f="30541" txt_i="23535" txt_f="23537">PM</offsets></sc><offsets xml_i="30546" xml_f="30547" txt_i="23537" txt_f="23538">/</offsets><sc><offsets xml_i="30551" xml_f="30553" txt_i="23538" txt_f="23540">AM</offsets></sc><offsets xml_i="30558" xml_f="31119" txt_i="23540" txt_f="24101"> split dosing of a similar preparation and found the split-dosing regimens produced significant better bowel preparations. The day before regimens produced good or excellent results in 39.4–56.2% of subjects, whereas the split-dosing regimens produced good or excellent results in 76.5–94.4%. In both studies, (1) subjects in the day before arms consumed a liquid diet the day before the colonoscopy; (2) subjects in the split-dosing arms consumed a regular diet the day before the colonoscopy; and (3) the 4-liter PEG-ELS preparations contained sodium sulfate.</offsets></p><p></p><p><offsets xml_i="31133" xml_f="31396" txt_i="24103" txt_f="24366">If colonoscopy preparations are sufficiently well tolerated and efficacious, split dosing may be unnecessary for morning procedures. Only head-to-head comparisons in randomized trials of these different bowel preparations will definitively answer these questions.</offsets></p><p><offsets xml_i="31403" xml_f="32421" txt_i="24367" txt_f="25385">In our study, 94.7% of subjects in the G/PEG arms combined were able to finish their preparations compared with 68.5% of subjects in the NU arm, but these findings do not explain why the colons were as clean in the G/PEG arms as they were in the NU arm. Subjects in the NU arm actually consumed an average of 392 g of PEG (93.4% of the prescribed amount) compared with 303 g (99.1% of the prescribed amount) in both G/PEG arms combined. The 31 subjects (15.5%) who consumed 139–315 g of PEG in their NuLYTELY (33–75% of the prescribed amount) had a significantly lower average BBPS compared with that of the 169 subjects (84.5%) who consumed 319–420 g of PEG in their NuLYTELY (76–100% of the prescribed amount). If the 31 subjects who consumed 33–75% of their NuLYTELY were excluded from the NU arm, the BBPS of the remaining 169 subjects would be very similar to the BBPS for the 400 subjects in both G/PEG arms combined. This is further evidence that 238–255 g of PEG may not be enough to reliably lavage the colon.</offsets></p><p><offsets xml_i="32428" xml_f="32440" txt_i="25386" txt_f="25398">Five studies</offsets><sup><xref ref-type="bibr" rid="bib15"><offsets xml_i="32479" xml_f="32481" txt_i="25398" txt_f="25400">15</offsets></xref><offsets xml_i="32488" xml_f="32490" txt_i="25400" txt_f="25402">, </offsets><xref ref-type="bibr" rid="bib22"><offsets xml_i="32524" xml_f="32526" txt_i="25402" txt_f="25404">22</offsets></xref><offsets xml_i="32533" xml_f="32535" txt_i="25404" txt_f="25406">, </offsets><xref ref-type="bibr" rid="bib23"><offsets xml_i="32569" xml_f="32571" txt_i="25406" txt_f="25408">23</offsets></xref><offsets xml_i="32578" xml_f="32580" txt_i="25408" txt_f="25410">, </offsets><xref ref-type="bibr" rid="bib24"><offsets xml_i="32614" xml_f="32616" txt_i="25410" txt_f="25412">24</offsets></xref><offsets xml_i="32623" xml_f="32625" txt_i="25412" txt_f="25414">, </offsets><xref ref-type="bibr" rid="bib25"><offsets xml_i="32659" xml_f="32661" txt_i="25414" txt_f="25416">25</offsets></xref></sup><offsets xml_i="32674" xml_f="33056" txt_i="25416" txt_f="25798"> have compared various 2-liter PEG-ELS solutions with 15–20 mg of bisacodyl to similar 4-liter PEG-ELS solutions without bisacodyl and concluded that there was no significant difference in cleanliness between the arms, and that the 2-liter preparations were better tolerated. None of these studies used both the SF-PEG-ELS and a sensitive and validated measure of colon cleanliness.</offsets></p><p><offsets xml_i="33063" xml_f="33200" txt_i="25799" txt_f="25936">It has been reported that the quality of colonoscopy preparations declines as the time between the preparation and colonoscopy increases.</offsets><sup><xref ref-type="bibr" rid="bib26"><offsets xml_i="33239" xml_f="33241" txt_i="25936" txt_f="25938">26</offsets></xref></sup><offsets xml_i="33254" xml_f="33475" txt_i="25938" txt_f="26159"> We found no significant difference between the BBPS of colonoscopies performed between 0800 and 0900 h compared with 1115 and 1200 h. It should be noted that by design in this study, no afternoon procedures were studied.</offsets></p><p><offsets xml_i="33482" xml_f="34299" txt_i="26160" txt_f="26977">This is the first study to use both the BBPS and the OPS to rate colon cleanliness. The colon segments rated on the BBPS (right, transverse, and left) were easier for the gastroenterologist to define during colonoscopy than those rated on the OPS (right, transverse/descending, and sigmoid/rectum). The BBPS rated each segment after washing and suctioning, whereas the OPS rated each segment before cleaning was attempted. The BBPS was more clinically relevant, because the visualization of the mucosa is the primary goal of any bowel preparation. The OPS was more sensitive to truly outstanding colon preparations, as it distinguished between segments that required no cleaning and those that required some cleaning. Despite these differences, the results on the BBPS and OPS were moderately-to-strongly correlated (</offsets><italic><offsets xml_i="34307" xml_f="34308" txt_i="26977" txt_f="26978">r</offsets></italic><offsets xml_i="34317" xml_f="34326" txt_i="26978" txt_f="26987">=−0.796).</offsets></p><p><offsets xml_i="34333" xml_f="34894" txt_i="26988" txt_f="27549">Both the BBPS and OPS suffer from poorly designed scoring systems that are not easily converted into the poor/fair/good/excellent subjective rating scale, which is often used by gastroenterologists in their colonoscopy reports. A colon with minor residual material throughout the colon would receive a BBPS=6, and most gastroenterologists would consider this a good preparation. A colon with a clean transverse and left colon, but with stool that could not be cleared throughout the right colon, would receive the same BBPS=6, but the preparation would be poor.</offsets></p><p><offsets xml_i="34901" xml_f="35571" txt_i="27550" txt_f="28220">A segment of colon is rated 1 on the BBPS, when a portion of mucosa in a segment is seen after cleaning, but other areas are not seen due to retained material. The BBPS does not specify the percentage of a segment's mucosa that must not be seen for it to be rated 1. Our adequate/inadequate scale required at least 95% of the mucosa of the whole colon to be well visualized for the preparation to be rated as adequate. It was possible for a segment of the colon to be rated 1 on the BBPS, yet the preparation of the whole colon on the adequate/inadequate scale to be rated as adequate. An improved scale to rate bowel cleanliness is needed to overcome these limitations.</offsets></p><p><offsets xml_i="35578" xml_f="35886" txt_i="28221" txt_f="28529">This study is being reported as an investigator-blinded study of G/PEG+P vs. G/PEG+B rather than a double-blinded study, because the placebo (folic acid) pills and bisacodyl pills looked very similar, but were not identical. To the best of our knowledge, patients did not know which pill they were consuming.</offsets></p><p><offsets xml_i="35893" xml_f="36445" txt_i="28530" txt_f="29082">In conclusion, we found the NU arm and both G/PEG arms produced statistically similar colon cleansing when consumed the day before a morning colonoscopy. Subjects in the G/PEG arms tolerated their preparations far better than those in the NU arm. G/PEG appears to be as safe as NU with small but statistically significant electrolyte differences among the arms, causing no clinical symptoms. G/PEG costs about 25% as much as commercially available low-volume colon-cleansing preparations, such as HalfLytely, MoviPrep, VISICOL tablets, and SUPREP (see </offsets><xref rid="tbl1" ref-type="table"><offsets xml_i="36479" xml_f="36486" txt_i="29082" txt_f="29089">Table 1</offsets></xref><offsets xml_i="36493" xml_f="36750" txt_i="29089" txt_f="29346">). Although a formal cost effectiveness analysis was not performed, using the G/PEG preparation described here could result in a very significant cost savings. In our practice, the G/PEG (without bisacodyl) is used for most colon cleansings for colonoscopy.</offsets></p><p><offsets xml_i="36757" xml_f="37095" txt_i="29347" txt_f="29685">Adding 10 mg of bisacodyl to G/PEG and 64 oz of Gatorade for colon lavage caused more abdominal bloating/cramps, and did not result in a cleaner colon. There is no evidence that bisacodyl is effective as part of a PEG colon-cleansing preparation and its widespread use as part of various colon-lavage preparations needs to be re-examined.</offsets></p><p><offsets xml_i="37102" xml_f="37556" txt_i="29686" txt_f="30140">Future studies need to determine: (1) if the G/PEG used in this study provides the optimal balance of colon cleansing with patient safety and tolerance; (2) if any clear liquid could be substituted for Gatorade; (3) how the G/PEG preparation compares with other commercially available preparations; (4) the safety of the G/PEG preparation in larger numbers of patients, including those with renal insufficiency and CHF; and (5) if the inconvenience of a </offsets><sc><offsets xml_i="37560" xml_f="37562" txt_i="30140" txt_f="30142">PM</offsets></sc><offsets xml_i="37567" xml_f="37568" txt_i="30142" txt_f="30143">/</offsets><sc><offsets xml_i="37572" xml_f="37574" txt_i="30143" txt_f="30145">AM</offsets></sc><offsets xml_i="37579" xml_f="37677" txt_i="30145" txt_f="30243"> split-dose G/PEG preparation is outweighed by the improved cleanliness for morning colonoscopies.</offsets></p></sec><sec><title><offsets xml_i="37699" xml_f="37715" txt_i="30245" txt_f="30261">Study Highlights</offsets></title><p><inline-graphic xlink:href="ctg201211i1.jpg"></inline-graphic></p></sec></body><back><ack><p>We thank our office personnel: Kathy, Karina, Ariana, Sena, Tammy, and Carla; and the Hinsdale Hospital GI lab nurses: Diane, Beth, Loretta, Minhee, Kate, Michelle, Mary Kay, Peggy, Kim, Sue, Jackie, and Marilyn, for their assistance. We also thank David Rubin, MD, for his editorial assistance.</p></ack><fn-group><fn><p><xref ref-type="supplementary-material" rid="sup1">Supplementary Information</xref> accompanies this paper on the <italic>Clinical and Translational Gastroenterology</italic> website (http://www.nature.com/ctg)</p></fn></fn-group><notes><p><bold>Guarantor of the article</bold>: David P. Gerard, MD.</p><p><bold>Specific author contributions</bold>: David P. Gerard: all. John L. Holden and Manfred W. Raiser: concept, acquisition of data, analysis, drafting, and critical revisions. Diane B. Foster: acquisition of data, analysis, drafting, critical revisions, and administrative.</p><p><bold>Financial support</bold>: None.</p><p><bold>Potential competing interests</bold>: None.</p></notes><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>LC</given-names></name><name><surname>Rim</surname><given-names>SH</given-names></name><name><surname>Plescia</surname><given-names>M</given-names></name></person-group><article-title>Vital signs: colorectal cancer screening among adults aged 50-75 - United States, 2008</article-title><source>Morb Mortal Wkly Rep</source><year>2010</year><volume>59</volume><fpage>808</fpage><lpage>812</lpage></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harewood</surname><given-names>GC</given-names></name><name><surname>Wiersema</surname><given-names>MJ</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names><suffix>III</suffix></name></person-group><article-title>A prospective, controlled assessment of factors influencing acceptance of screen colonoscopy</article-title><source>Am J Gastroenterol</source><year>2002</year><volume>97</volume><fpage>3186</fpage><lpage>3194</lpage><pub-id pub-id-type="pmid">12492209</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>GR</given-names></name><name><surname>Santa Ana</surname><given-names>CA</given-names></name><name><surname>Morawski</surname><given-names>SG</given-names></name><etal></etal></person-group><article-title>Development of a lavage solution associated with minimal water and electrolyte absorption or secretion</article-title><source>Gastroenterology</source><year>1980</year><volume>78</volume><fpage>991</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">7380204</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>ASGE</collab></person-group><article-title>A consensus document on bowel preparation before colonoscopy: prepared by a Tast Force from the ASCRS, the ASGE, and the SAGES</article-title><source>Gastrointest Endosc</source><year>2006</year><volume>63</volume><fpage>894</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">16733101</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPalma</surname><given-names>JA</given-names></name><name><surname>Marshall</surname><given-names>JB</given-names></name></person-group><article-title>Comparison of a new sulfate-free polyethylene glycol electrolyte lavage solution versus a standard solution for colonoscopy cleansing</article-title><source>Gastrointest Endosc</source><year>1990</year><volume>36</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">2365214</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Stokes</surname><given-names>MB</given-names></name><name><surname>Radhakrishnon</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>15</volume><fpage>3389</fpage><lpage>3396</lpage><pub-id pub-id-type="pmid">16192415</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Vanner</surname><given-names>SJ</given-names></name></person-group><article-title>Colon cleansing before colonoscopy: does oral sodium phosphate solution still make sense</article-title><source>Can J Gastroenterol</source><year>2009</year><volume>23</volume><fpage>210</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">19319385</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belsey</surname><given-names>J</given-names></name><name><surname>Epstein</surname><given-names>O</given-names></name><name><surname>Herebach</surname><given-names>D</given-names></name></person-group><article-title>Systematic review: oral bowel preparation for colonoscopy</article-title><source>Aliment Pharmacol Ther</source><year>2007</year><volume>25</volume><fpage>373</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">17269992</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enestvedt</surname><given-names>BK</given-names></name><name><surname>Fennerty</surname><given-names>MB</given-names></name><name><surname>Eisen</surname><given-names>GM</given-names></name></person-group><article-title>Randomized clinical trial: PEG vs. GoLYTELY - a controlled study of efficacy and patient tolerability in bowel preparation for colonoscopy</article-title><source>Aliment Pharmacol Ther</source><year>2011</year><volume>33</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">21083586</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjelkrem</surname><given-names>M</given-names></name><name><surname>Stengel</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>DP</given-names></name><etal></etal></person-group><article-title>MiraLAX is not as effective as GoLYTELY in bowel cleaning before screening colonoscopy</article-title><source>Clin Gastroenterol Hepatol</source><year>2011</year><volume>9</volume><fpage>326</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">21115134</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>EJ</given-names></name><name><surname>Calderwood</surname><given-names>AH</given-names></name><name><surname>Doros</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>The Boston Bowel Preparation scale: a valid and reliable instrument for colonoscopy oriented research</article-title><source>Gastrointest Endosc</source><year>2009</year><volume>69</volume><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">19136102</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostom</surname><given-names>A</given-names></name><name><surname>Jolicoeur</surname><given-names>E</given-names></name></person-group><article-title>Validation of a new scale for the assessment of bowel preparation quality</article-title><source>Gastrointest Endosc</source><year>2004</year><volume>59</volume><fpage>482</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">15044882</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardy</surname><given-names>CE</given-names><suffix>III</suffix></name><name><surname>Dipalma</surname><given-names>JA</given-names></name><name><surname>Beck</surname><given-names>DE</given-names></name></person-group><article-title>Effect of bisacodyl on gut lavage cleaning for colonoscopy</article-title><source>Ann Clin Res</source><year>1987</year><volume>19</volume><fpage>34</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">3555277</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPalma</surname><given-names>JA</given-names></name><name><surname>McGowan</surname><given-names>J</given-names></name><name><surname>Cleveland</surname><given-names>V</given-names></name></person-group><article-title>Clinical trial: an efficacy evaluation of reduced bisacodyl given as part of a polyethylene glycol electrolyte solution preparation prior to colonoscopy</article-title><source>Aliment Pharmacol Ther</source><year>2007</year><volume>26</volume><fpage>1113</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">17894653</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPalma</surname><given-names>JA</given-names></name><name><surname>Wolff</surname><given-names>BG</given-names></name><name><surname>Meagher</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Comparison of reduced volume versus four liters sulfate-free electrolyte lavage solutions for colonoscopy colon cleansing</article-title><source>Am J Gastroenterol</source><year>2003</year><volume>98</volume><fpage>2187</fpage><lpage>2191</lpage><pub-id pub-id-type="pmid">14572566</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>DiPalma</surname><given-names>JA</given-names></name><name><surname>Rodriguez</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy</article-title><source>Gastrointest Endosc</source><year>2010</year><volume>72</volume><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">20646695</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagler</surname><given-names>J</given-names></name><name><surname>Poppers</surname><given-names>D</given-names></name><name><surname>Turetz</surname><given-names>M</given-names></name></person-group><article-title>Severe hyponatremia and seizure following a polyethylene glycol-based bowel preparation for colonoscopy</article-title><source>J Clin Gastroenterol</source><year>2006</year><volume>40</volume><fpage>558</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">16825941</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Schoenfeld</surname><given-names>P</given-names></name></person-group><article-title>Severe hyponatremia and MiraLax-Gatorade bowel preparation (abstract)</article-title><source>Am J Gastroenterol</source><year>2011</year><volume>106</volume><fpage>S582</fpage></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>DK</given-names></name><name><surname>Johnson</surname><given-names>DA</given-names></name><name><surname>Anderson</surname><given-names>JC</given-names></name><etal></etal></person-group><article-title>American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2009</article-title><source>Am J Gastroenterol</source><year>2009</year><volume>104</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">19240699</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoun</surname><given-names>E</given-names></name><name><surname>Abdul-Baki</surname><given-names>H</given-names></name><name><surname>Azar</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>A randomized single-blind trial of split-dose PEG-electrolyte solution without dietary restrictions compared to whole dose PEG-electrolyte solution with dietary restriction for colonoscopy preparation</article-title><source>Gastrointest Endosc</source><year>2005</year><volume>62</volume><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">16046981</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul-Baki</surname><given-names>H</given-names></name><name><surname>Hashash</surname><given-names>JG</given-names></name><name><surname>ElHajj</surname><given-names>II</given-names></name><etal></etal></person-group><article-title>A randomized, controlled, double-blind trail of the adjunct use of tegaserod in whole-dose or split-dose polyethylene glycol electrolyte solution for colonoscopy preparation</article-title><source>Gastrointest Endosc</source><year>2008</year><volume>68</volume><fpage>294</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">18511049</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>WJ</given-names></name><name><surname>Meaghher</surname><given-names>AP</given-names></name><name><surname>Lubowski</surname><given-names>DZ</given-names></name><etal></etal></person-group><article-title>Bisacodyl reduces the volume of polyethylene glycol solution required for bowel preparation</article-title><source>Dis Colon Rectum</source><year>1994</year><volume>37</volume><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">8137669</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>VK</given-names></name><name><surname>Chockalingham</surname><given-names>SK</given-names></name><name><surname>Ugheoke</surname><given-names>EA</given-names></name><etal></etal></person-group><article-title>Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation</article-title><source>Gastrointest Endosc</source><year>1998</year><volume>47</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">9512283</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ker</surname><given-names>TS</given-names></name></person-group><article-title>Comparison of reduced volume versus four-liter electrolyte lavage solutions for colon cleansing</article-title><source>Am Surg</source><year>2006</year><volume>72</volume><fpage>909</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">17058733</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ker</surname><given-names>TS</given-names></name></person-group><article-title>Prospective comparison of three bowel preparation regimens: Fleet Phosphosoda, two-liter and four liter electrolyte lavage solutions</article-title><source>Am Surg</source><year>2008</year><volume>74</volume><fpage>1030</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">18942638</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>AA</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Spechler</surname><given-names>SJ</given-names></name><etal></etal></person-group><article-title>Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality</article-title><source>Gastrointest Endosc</source><year>2009</year><volume>69</volume><fpage>700</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">19251013</pub-id></mixed-citation></ref></ref-list><sec sec-type="supplementary-material" id="sup1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="xob1"><label>Supplementary Information 1</label><media mimetype="application" mime-subtype="msword" xlink:href="ctg201211x1.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="xob2"><label>Supplementary Information 2</label><media mimetype="application" mime-subtype="msword" xlink:href="ctg201211x2.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="xob3"><label>Supplementary Information 3</label><media mimetype="application" mime-subtype="msword" xlink:href="ctg201211x3.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="xob4"><label>Supplementary Information 4</label><media mimetype="application" mime-subtype="msword" xlink:href="ctg201211x4.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></back><floats-group><table-wrap id="tbl1"><label>Table 1</label><caption><title>Select colon lavage preparations available for sale in the United States</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>CoLyte or GoLYTELY</bold></th><th align="center" valign="top" charoff="50"><bold>TriLyte or NuLYTELY</bold></th><th align="center" valign="top" charoff="50"><bold>HalfLytely</bold></th><th align="center" valign="top" charoff="50"><bold>MoviPrep</bold></th><th align="center" valign="top" charoff="50"><bold>Gatorade+ PEG</bold></th><th align="center" valign="top" charoff="50"><bold>VISICOL #32 tablets</bold></th><th align="center" valign="top" charoff="50"><bold>SUPREP</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">Sodium bicarbonate (g)</td><td align="center" valign="top" charoff="50">6.74</td><td align="center" valign="top" charoff="50">5.72</td><td align="center" valign="top" charoff="50">2.86</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sodium chloride (g)</td><td align="center" valign="top" charoff="50">5.86</td><td align="center" valign="top" charoff="50">11.2</td><td align="center" valign="top" charoff="50">5.6</td><td align="center" valign="top" charoff="50">5.38</td><td align="center" valign="top" charoff="50">1.19</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sodium sulfate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">22.74</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">15</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">35</td></tr><tr><td align="left" valign="top" charoff="50">Sodium citrate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">0.68</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sodium phosphate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">48</td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Potasium-H<sub>2</sub>-phosphate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">0.84</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Potassium chloride (g)</td><td align="center" valign="top" charoff="50">2.97</td><td align="center" valign="top" charoff="50">1.48</td><td align="center" valign="top" charoff="50">0.74</td><td align="center" valign="top" charoff="50">2.03</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Potassium sulfate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">6.26</td></tr><tr><td align="left" valign="top" charoff="50">PEG-3350 (g)</td><td align="center" valign="top" charoff="50">236</td><td align="center" valign="top" charoff="50">420</td><td align="center" valign="top" charoff="50">210</td><td align="center" valign="top" charoff="50">200</td><td align="center" valign="top" charoff="50">306</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sodium ascorbate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">11.8</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Ascorbic acid (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">9.4</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Magnesium sulfate (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">3.2</td></tr><tr><td align="left" valign="top" charoff="50">Fructose/sucrose (g)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"></td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Water (ml)</td><td align="center" valign="top" charoff="50">4000</td><td align="center" valign="top" charoff="50">4000</td><td align="center" valign="top" charoff="50">2000</td><td align="center" valign="top" charoff="50">2000</td><td align="center" valign="top" charoff="50">2247</td><td align="center" valign="top" charoff="50">2000</td><td align="center" valign="top" charoff="50">2839</td></tr><tr><td align="left" valign="top" charoff="50">Sodium (mmol)</td><td align="center" valign="top" charoff="50">500</td><td align="center" valign="top" charoff="50">260</td><td align="center" valign="top" charoff="50">130</td><td align="center" valign="top" charoff="50">363.6</td><td align="center" valign="top" charoff="50">38</td><td align="center" valign="top" charoff="50">416</td><td align="center" valign="top" charoff="50">493</td></tr><tr><td align="left" valign="top" charoff="50">Potassium (mmol)</td><td align="center" valign="top" charoff="50">40</td><td align="center" valign="top" charoff="50">20</td><td align="center" valign="top" charoff="50">10</td><td align="center" valign="top" charoff="50">28.4</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">71</td></tr><tr><td align="left" valign="top" charoff="50">Magnesium (mmol)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">27</td></tr><tr><td align="left" valign="top" charoff="50">Chloride (mmol)</td><td align="center" valign="top" charoff="50">140</td><td align="center" valign="top" charoff="50">212</td><td align="center" valign="top" charoff="50">106</td><td align="center" valign="top" charoff="50">119.6</td><td align="center" valign="top" charoff="50">20</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Bicarbonate (mmol)</td><td align="center" valign="top" charoff="50">80</td><td align="center" valign="top" charoff="50">68</td><td align="center" valign="top" charoff="50">34</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sulfate (mmol)</td><td align="center" valign="top" charoff="50">160</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">105.6</td><td align="center" valign="top" charoff="50">308</td></tr><tr><td align="left" valign="top" charoff="50">Phosphate (mmol)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">326</td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Ascorbate (mmol)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">59.6</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Citrate (mmol)</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">PEG-3350 (mmol)</td><td align="center" valign="top" charoff="50">70.4</td><td align="center" valign="top" charoff="50">125.2</td><td align="center" valign="top" charoff="50">62.6</td><td align="center" valign="top" charoff="50">59.2</td><td align="center" valign="top" charoff="50">91.2</td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Cost ($)</td><td align="center" valign="top" charoff="50">16.78</td><td align="center" valign="top" charoff="50">25.32</td><td align="center" valign="top" charoff="50">63.68</td><td align="center" valign="top" charoff="50">64.84</td><td align="center" valign="top" charoff="50">16.56</td><td align="center" valign="top" charoff="50">66.68</td><td align="center" valign="top" charoff="50">80.32</td></tr></tbody></table><table-wrap-foot><fn id="t1-fn1"><p>Contents obtained from the package inserts. Cost data for patients paying cash at Wal-Mart in January 2011 in Illinois, USA, for the least-expensive version (generic if available).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2"><label>Table 2</label><caption><title>The BBPS<sup><xref ref-type="bibr" rid="bib11">11</xref></sup> and the OPS<sup><xref ref-type="bibr" rid="bib12">12</xref></sup></title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col></colgroup><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><italic>BBPS rating for each colon segment</italic></td></tr><tr><td align="left" valign="top" charoff="50"> 0=Unprepared colon segment with stool that cannot be cleared</td></tr><tr><td align="left" valign="top" charoff="50"> 1=Portion of mucosa in segment seen after cleaning, but other areas not seen due to retained material</td></tr><tr><td align="left" valign="top" charoff="50"> 2=Minor residual material after cleaning, but mucosa of segment generally well seen</td></tr><tr><td align="left" valign="top" charoff="50"> 3=Entire mucosa of segment well seen after washing</td></tr><tr><td align="left" valign="top" charoff="50">BBPS is calculated by adding the ratings of the right, transverse and left colon segments. The overall BBPS is reported from 0 (very poor) to 9 (excellent)</td></tr><tr><td align="left" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50"><italic>OPS rating for each colon segment</italic></td></tr><tr><td align="left" valign="top" charoff="50"> 4=Inadequate (solid stool not cleared with washing and suctioning)</td></tr><tr><td align="left" valign="top" charoff="50"> 3=Poor (necessary to wash and suction to obtain a reasonable view)</td></tr><tr><td align="left" valign="top" charoff="50"> 2=Fair (necessary to suction liquid to adequately view segment)</td></tr><tr><td align="left" valign="top" charoff="50"> 1=Good (minimal turbid fluid in segment)</td></tr><tr><td align="left" valign="top" charoff="50"> 0=Excellent (mucosal detail clearly visible)</td></tr><tr><td align="left" valign="top" charoff="50"><italic>OPS rating for the amount of fluid in the whole colon</italic></td></tr><tr><td align="left" valign="top" charoff="50"> 2=Lots of fluid</td></tr><tr><td align="left" valign="top" charoff="50"> 1=Moderate fluid</td></tr><tr><td align="left" valign="top" charoff="50"> 0=Little fluid</td></tr><tr><td align="left" valign="top" charoff="50">OPS is calculated by adding the ratings of the right, transverse/descending and sigmoid/rectum colon segments, and rating for the fluid in the whole colon. The overall OPS is reported from 14 (very poor) to 0 (excellent)</td></tr></tbody></table><table-wrap-foot><fn id="t2-fn1"><p>Abbreviations: BBPS, Boston Bowel Preparation Scale; OPS, Ottawa Preparation Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3"><label>Table 3</label><caption><title>Data from the questionnaire filled out by the gastroenterologists immediately after the colonoscopy</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="char" char="."></col><col align="center"></col><col align="char" char="."></col><col align="char" char="."></col><col align="center"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>1 NuLYTELY or TriLyte</bold></th><th align="center" valign="top" charoff="50"><bold>2 Gatorade/PEG with placebo</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 2</bold></th><th align="center" valign="top" charoff="50"><bold>3 Gatorade/PEG with 10 mg bisacodyl</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 2 vs. 3</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 3</bold></th><th align="center" valign="top" charoff="50"><bold>4 Gatorade/PEG (both arms)</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 4</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><italic>N</italic></td><td align="center" valign="top" charoff="50">200</td><td align="center" valign="top" charoff="50">200</td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50">200</td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50">400</td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Sex ratio (M:F)</td><td align="center" valign="top" charoff="50">119: 81</td><td align="center" valign="top" charoff="50">109: 91</td><td align="char" valign="top" char="." charoff="50">0.31</td><td align="center" valign="top" charoff="50">101: 99</td><td align="char" valign="top" char="." charoff="50">0.42</td><td align="char" valign="top" char="." charoff="50">0.07</td><td align="center" valign="top" charoff="50">210: 190</td><td align="char" valign="top" char="." charoff="50">0.06</td></tr><tr><td align="left" valign="top" charoff="50">MD (Gerard: Raiser: Holden)</td><td align="center" valign="top" charoff="50">100: 57: 43</td><td align="center" valign="top" charoff="50">95: 64: 41</td><td align="char" valign="top" char="." charoff="50">0.75</td><td align="center" valign="top" charoff="50">85: 71: 44</td><td align="char" valign="top" char="." charoff="50">0.60</td><td align="char" valign="top" char="." charoff="50">0.25</td><td align="center" valign="top" charoff="50">180: 135: 85</td><td align="char" valign="top" char="." charoff="50">0.39</td></tr><tr><td align="left" valign="top" charoff="50">Age in years (mean±s.d.)</td><td align="center" valign="top" charoff="50">60.2±13.2</td><td align="center" valign="top" charoff="50">59.7±13.8</td><td align="char" valign="top" char="." charoff="50">0.71</td><td align="center" valign="top" charoff="50">61.3±12.5</td><td align="char" valign="top" char="." charoff="50">0.22</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="center" valign="top" charoff="50">60.4±13.1</td><td align="char" valign="top" char="." charoff="50">0.86</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Race</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Caucasian</td><td align="char" valign="top" char="." charoff="50">173</td><td align="char" valign="top" char="." charoff="50">168</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="." charoff="50">173</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">341</td><td align="char" valign="top" char="." charoff="50">0.68</td></tr><tr><td align="left" valign="top" charoff="50"> African American</td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.63</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">0.10</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="." charoff="50">14</td><td align="char" valign="top" char="." charoff="50">0.76</td></tr><tr><td align="left" valign="top" charoff="50"> Hispanic</td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.40</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.40</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.31</td></tr><tr><td align="left" valign="top" charoff="50"> Other</td><td align="char" valign="top" char="." charoff="50">11</td><td align="char" valign="top" char="." charoff="50">17</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="." charoff="50">18</td><td align="char" valign="top" char="." charoff="50">0.86</td><td align="char" valign="top" char="." charoff="50">0.18</td><td align="char" valign="top" char="." charoff="50">35</td><td align="char" valign="top" char="." charoff="50">0.16</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Procedure</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Performed in our office</td><td align="char" valign="top" char="." charoff="50">115</td><td align="char" valign="top" char="." charoff="50">113</td><td align="char" valign="top" char="." charoff="50">0.84</td><td align="char" valign="top" char="." charoff="50">123</td><td align="char" valign="top" char="." charoff="50">0.31</td><td align="char" valign="top" char="." charoff="50">0.42</td><td align="char" valign="top" char="." charoff="50">236</td><td align="char" valign="top" char="." charoff="50">0.73</td></tr><tr><td align="left" valign="top" charoff="50"> Start time (mean hour±s.d.)</td><td align="center" valign="top" charoff="50">10.2±0.9</td><td align="center" valign="top" charoff="50">10.3±1.0</td><td align="char" valign="top" char="." charoff="50">0.29</td><td align="center" valign="top" charoff="50">10.2±1.0</td><td align="char" valign="top" char="." charoff="50">0.29</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">10.3±1.0</td><td align="char" valign="top" char="." charoff="50">0.23</td></tr><tr><td align="left" valign="top" charoff="50">History of heart failure</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">1</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">1</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0.55</td></tr><tr><td align="left" valign="top" charoff="50">Baseline creatinine level ≥1.30</td><td align="center" valign="top" charoff="50">9</td><td align="center" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="center" valign="top" charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="." charoff="50">0.28</td><td align="center" valign="top" charoff="50">12</td><td align="char" valign="top" char="." charoff="50">0.35</td></tr><tr><td align="left" valign="top" charoff="50">Previous colon resection</td><td align="center" valign="top" charoff="50">8</td><td align="center" valign="top" charoff="50">9</td><td align="char" valign="top" char="." charoff="50">0.81</td><td align="center" valign="top" charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.81</td><td align="char" valign="top" char="." charoff="50">0.63</td><td align="center" valign="top" charoff="50">19</td><td align="char" valign="top" char="." charoff="50">0.68</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Indications (multiple indications possible)</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Screening</td><td align="char" valign="top" char="." charoff="50">70</td><td align="char" valign="top" char="." charoff="50">67</td><td align="char" valign="top" char="." charoff="50">0.75</td><td align="char" valign="top" char="." charoff="50">59</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="." charoff="50">126</td><td align="char" valign="top" char="." charoff="50">0.39</td></tr><tr><td align="left" valign="top" charoff="50"> History of polyps</td><td align="char" valign="top" char="." charoff="50">41</td><td align="char" valign="top" char="." charoff="50">56</td><td align="char" valign="top" char="." charoff="50">0.08</td><td align="char" valign="top" char="." charoff="50">62</td><td align="char" valign="top" char="." charoff="50">0.51</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="." charoff="50">118</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.05</bold></td></tr><tr><td align="left" valign="top" charoff="50"> History of colon cancer</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.52</td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50">0.58</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="." charoff="50">14</td><td align="char" valign="top" char="." charoff="50">0.31</td></tr><tr><td align="left" valign="top" charoff="50"> FH colon neoplasia</td><td align="char" valign="top" char="." charoff="50">28</td><td align="char" valign="top" char="." charoff="50">29</td><td align="char" valign="top" char="." charoff="50">0.89</td><td align="char" valign="top" char="." charoff="50">30</td><td align="char" valign="top" char="." charoff="50">0.89</td><td align="char" valign="top" char="." charoff="50">0.78</td><td align="char" valign="top" char="." charoff="50">59</td><td align="char" valign="top" char="." charoff="50">0.81</td></tr><tr><td align="left" valign="top" charoff="50"> Rectal bleeding</td><td align="char" valign="top" char="." charoff="50">39</td><td align="char" valign="top" char="." charoff="50">34</td><td align="char" valign="top" char="." charoff="50">0.52</td><td align="char" valign="top" char="." charoff="50">39</td><td align="char" valign="top" char="." charoff="50">0.52</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">73</td><td align="char" valign="top" char="." charoff="50">0.71</td></tr><tr><td align="left" valign="top" charoff="50"> Anemia</td><td align="char" valign="top" char="." charoff="50">14</td><td align="char" valign="top" char="." charoff="50">11</td><td align="char" valign="top" char="." charoff="50">0.54</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.21</td><td align="char" valign="top" char="." charoff="50">0.07</td><td align="char" valign="top" char="." charoff="50">17</td><td align="char" valign="top" char="." charoff="50">0.15</td></tr><tr><td align="left" valign="top" charoff="50"> History of IBD</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.05</bold></td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.05</bold></td><td align="char" valign="top" char="." charoff="50">13</td><td align="char" valign="top" char="." charoff="50">0.16</td></tr><tr><td align="left" valign="top" charoff="50"> Diarrhea</td><td align="char" valign="top" char="." charoff="50">11</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.21</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.21</td><td align="char" valign="top" char="." charoff="50">12</td><td align="char" valign="top" char="." charoff="50">0.13</td></tr><tr><td align="left" valign="top" charoff="50"> Recent diverticulitis</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">0.37</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.28</td></tr><tr><td align="left" valign="top" charoff="50"> Abnormal GI X-ray</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0.50</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.50</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0.55</td></tr><tr><td align="left" valign="top" charoff="50"> Change in bowel habits</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.06</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">0.22</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.19</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Findings (multiple findings possible)</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Normal</td><td align="char" valign="top" char="." charoff="50">61</td><td align="char" valign="top" char="." charoff="50">59</td><td align="char" valign="top" char="." charoff="50">0.82</td><td align="char" valign="top" char="." charoff="50">53</td><td align="char" valign="top" char="." charoff="50">0.50</td><td align="char" valign="top" char="." charoff="50">0.37</td><td align="char" valign="top" char="." charoff="50">112</td><td align="char" valign="top" char="." charoff="50">0.52</td></tr><tr><td align="left" valign="top" charoff="50"> Colon polyps</td><td align="char" valign="top" char="." charoff="50">99</td><td align="char" valign="top" char="." charoff="50">100</td><td align="char" valign="top" char="." charoff="50">0.92</td><td align="char" valign="top" char="." charoff="50">102</td><td align="char" valign="top" char="." charoff="50">0.84</td><td align="char" valign="top" char="." charoff="50">0.76</td><td align="char" valign="top" char="." charoff="50">202</td><td align="char" valign="top" char="." charoff="50">0.82</td></tr><tr><td align="left" valign="top" charoff="50"> Colon cancer</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.67</td></tr><tr><td align="left" valign="top" charoff="50"> Diverticulosis</td><td align="char" valign="top" char="." charoff="50">78</td><td align="char" valign="top" char="." charoff="50">59</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.05</bold></td><td align="char" valign="top" char="." charoff="50">61</td><td align="char" valign="top" char="." charoff="50">0.82</td><td align="char" valign="top" char="." charoff="50">0.07</td><td align="char" valign="top" char="." charoff="50">120</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.03</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Crohn's disease</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.008</bold></td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.04</bold></td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50">0.28</td></tr><tr><td align="left" valign="top" charoff="50"> Ulcerative colitis</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.45</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.45</td><td align="char" valign="top" char="." charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.35</td></tr><tr><td align="left" valign="top" charoff="50"> Other colitis</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0.69</td><td align="char" valign="top" char="." charoff="50">0.69</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.74</td></tr><tr><td align="left" valign="top" charoff="50">Incomplete colonoscopy</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">3</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">4</td><td align="char" valign="top" char="." charoff="50">0.69</td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p>Abbreviations: M, male; F, female; IBD, inflammatory bowel disease; GI, gastrointestinal tract. <italic>P</italic>-values in bold signify significance levels &lt;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4"><label>Table 4</label><caption><title>Colon cleanliness data from the questionnaire filled out by the gastroenterologists immediately after the colonoscopy</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col><col align="center"></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>1 NuLYTELY or TriLyte</bold></th><th align="center" valign="top" charoff="50"><bold></bold></th><th align="center" valign="top" charoff="50"><bold><italic>P</italic>-value 1 vs. 2</bold></th><th align="center" valign="top" charoff="50"><bold>3 Gatorade/ PEG with 10 mg bisacodyl</bold></th><th align="center" valign="top" charoff="50"><bold><italic>P</italic>-value 2 vs. 3</bold></th><th align="center" valign="top" charoff="50"><bold><italic>P</italic>-value 1 vs. 3</bold></th><th align="center" valign="top" charoff="50"><bold>4 Gatorade/ PEG (both arms)</bold></th><th align="center" valign="top" charoff="50"><bold><italic>P</italic>-value 1 vs. 4</bold></th></tr></thead><tbody valign="top"><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>BBPS</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Right colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">2.45±0.67</td><td align="char" valign="top" char="±" charoff="50">2.49±0.60</td><td align="char" valign="top" char="." charoff="50">0.53</td><td align="char" valign="top" char="±" charoff="50">2.53±0.63</td><td align="char" valign="top" char="." charoff="50">0.52</td><td align="char" valign="top" char="." charoff="50">0.22</td><td align="char" valign="top" char="±" charoff="50">2.51±0.61</td><td align="char" valign="top" char="." charoff="50">0.27</td></tr><tr><td align="left" valign="top" charoff="50"> Transverse colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">2.70±0.53</td><td align="char" valign="top" char="±" charoff="50">2.78±0.48</td><td align="char" valign="top" char="." charoff="50">0.11</td><td align="char" valign="top" char="±" charoff="50">2.74±0.47</td><td align="char" valign="top" char="." charoff="50">0.40</td><td align="char" valign="top" char="." charoff="50">0.42</td><td align="char" valign="top" char="±" charoff="50">2.76±0.47</td><td align="char" valign="top" char="." charoff="50">0.16</td></tr><tr><td align="left" valign="top" charoff="50"> Left colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">2.71±0.58</td><td align="char" valign="top" char="±" charoff="50">2.77±0.49</td><td align="char" valign="top" char="." charoff="50">0.26</td><td align="char" valign="top" char="±" charoff="50">2.72±0.55</td><td align="char" valign="top" char="." charoff="50">0.44</td><td align="char" valign="top" char="." charoff="50">0.86</td><td align="char" valign="top" char="±" charoff="50">2.75±0.51</td><td align="char" valign="top" char="." charoff="50">0.39</td></tr><tr><td align="left" valign="top" charoff="50"> Total BBPS (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">7.86±1.55</td><td align="char" valign="top" char="±" charoff="50">8.05±1.28</td><td align="char" valign="top" char="." charoff="50">0.18</td><td align="char" valign="top" char="±" charoff="50">7.99±1.41</td><td align="char" valign="top" char="." charoff="50">0.66</td><td align="char" valign="top" char="." charoff="50">0.38</td><td align="char" valign="top" char="±" charoff="50">8.02±1.34</td><td align="char" valign="top" char="." charoff="50">0.19</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>OPS</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Right colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">1.18±0.96</td><td align="char" valign="top" char="±" charoff="50">1.14±0.95</td><td align="char" valign="top" char="." charoff="50">0.68</td><td align="char" valign="top" char="±" charoff="50">1.07±0.88</td><td align="char" valign="top" char="." charoff="50">0.44</td><td align="char" valign="top" char="." charoff="50">0.23</td><td align="char" valign="top" char="±" charoff="50">1.11±0.91</td><td align="char" valign="top" char="." charoff="50">0.38</td></tr><tr><td align="left" valign="top" charoff="50"> Transverse/descending colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.66±0.79</td><td align="char" valign="top" char="±" charoff="50">0.58±0.83</td><td align="char" valign="top" char="." charoff="50">0.32</td><td align="char" valign="top" char="±" charoff="50">0.57±0.73</td><td align="char" valign="top" char="." charoff="50">0.90</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="±" charoff="50">0.58±0.79</td><td align="char" valign="top" char="." charoff="50">0.24</td></tr><tr><td align="left" valign="top" charoff="50">  Sigmoid/rectum (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.60±0.86</td><td align="char" valign="top" char="±" charoff="50">0.53±0.77</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="char" valign="top" char="±" charoff="50">0.67±0.87</td><td align="char" valign="top" char="." charoff="50">0.09</td><td align="char" valign="top" char="." charoff="50">0.42</td><td align="char" valign="top" char="±" charoff="50">0.60±0.83</td><td align="char" valign="top" char="." charoff="50">1.00</td></tr><tr><td align="left" valign="top" charoff="50"> Fluid total colon (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.35±0.55</td><td align="char" valign="top" char="±" charoff="50">0.32±0.49</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="±" charoff="50">0.39±0.59</td><td align="char" valign="top" char="." charoff="50">0.20</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="±" charoff="50">0.36±0.54</td><td align="char" valign="top" char="." charoff="50">0.83</td></tr><tr><td align="left" valign="top" charoff="50"> Total OPS (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">2.80±2.24</td><td align="char" valign="top" char="±" charoff="50">2.58±2.47</td><td align="char" valign="top" char="." charoff="50">0.35</td><td align="char" valign="top" char="±" charoff="50">2.71±2.47</td><td align="char" valign="top" char="." charoff="50">0.60</td><td align="char" valign="top" char="." charoff="50">0.70</td><td align="char" valign="top" char="±" charoff="50">2.65±2.47</td><td align="char" valign="top" char="." charoff="50">0.47</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Inadequate preparation</td><td align="center" valign="top" charoff="50">11</td><td align="center" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.33</td><td align="center" valign="top" charoff="50">9</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="char" valign="top" char="." charoff="50">0.65</td><td align="center" valign="top" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">0.40</td></tr><tr><td align="left" valign="top" charoff="50">Failed or inadequate Preparation</td><td align="center" valign="top" charoff="50">13</td><td align="center" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.17</td><td align="center" valign="top" charoff="50">9</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="char" valign="top" char="." charoff="50">0.38</td><td align="center" valign="top" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">0.18</td></tr></tbody></table><table-wrap-foot><fn id="t4-fn1"><p>Abbreviations: BBPS, Boston Bowel Preparation Scale; OPS, Ottawa Preparation Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl5"><label>Table 5</label><caption><title>Data from the basic metabolic profiles drawn before the IV for the colonoscopy was started in subjects with no known pre-existing renal disease</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="center"></col><col align="center"></col><col align="char" char="."></col><col align="center"></col><col align="char" char="."></col><col align="char" char="."></col><col align="center"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" charoff="50"><bold>1 NuLYTELY or TriLyte</bold></th><th align="center" valign="top" charoff="50"><bold>2 Gatorade/ PEG with placebo</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 2</bold></th><th align="center" valign="top" charoff="50"><bold>3 Gatorade/ PEG with 10 mg bisacodyl</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 2 vs. 3</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 3</bold></th><th align="center" valign="top" charoff="50"><bold>4 Gatorade/ PEG (both arms)</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 4</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50"><italic>Subjects with no known renal disease (</italic>N)</td><td align="center" valign="top" charoff="50">191</td><td align="center" valign="top" charoff="50">193</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="center" valign="top" charoff="50">195</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="." charoff="50">0.28</td><td align="center" valign="top" charoff="50">388</td><td align="char" valign="top" char="." charoff="50">0.35</td></tr><tr><td align="left" valign="top" charoff="50"> Na (mmol/l) (mean±s.d.)</td><td align="center" valign="top" charoff="50">139.8±2.6</td><td align="center" valign="top" charoff="50">138.8±3.0</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0005</bold></td><td align="center" valign="top" charoff="50">139.3±2.5</td><td align="char" valign="top" char="." charoff="50">0.08</td><td align="char" valign="top" char="." charoff="50">0.05</td><td align="center" valign="top" charoff="50">139.0±2.7</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0007</bold></td></tr><tr><td align="left" valign="top" charoff="50"> K (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">4.29±0.42</td><td align="char" valign="top" char="±" charoff="50">4.26±0.44</td><td align="char" valign="top" char="." charoff="50">0.49</td><td align="char" valign="top" char="±" charoff="50">4.25±0.42</td><td align="char" valign="top" char="." charoff="50">0.82</td><td align="char" valign="top" char="." charoff="50">0.35</td><td align="char" valign="top" char="±" charoff="50">4.26±0.43</td><td align="char" valign="top" char="." charoff="50">0.43</td></tr><tr><td align="left" valign="top" charoff="50"> Cl (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">104.1±2.7</td><td align="char" valign="top" char="±" charoff="50">103.4±3.1</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">103.4±2.9</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">103.4±3.0</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.007</bold></td></tr><tr><td align="left" valign="top" charoff="50"> CO<sub>2</sub> (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">23.7±2.3</td><td align="char" valign="top" char="±" charoff="50">23.7±2.3</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">23.8±2.4</td><td align="char" valign="top" char="." charoff="50">0.68</td><td align="char" valign="top" char="." charoff="50">0.68</td><td align="char" valign="top" char="±" charoff="50">23.8±2.3</td><td align="char" valign="top" char="." charoff="50">0.62</td></tr><tr><td align="left" valign="top" charoff="50"> BUN (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">13.1±3.9</td><td align="char" valign="top" char="±" charoff="50">11.3±3.9</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">12.0±4.2</td><td align="char" valign="top" char="." charoff="50">0.09</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.008</bold></td><td align="char" valign="top" char="±" charoff="50">11.6±4.0</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Cre (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.95±0.18</td><td align="char" valign="top" char="±" charoff="50">0.94±0.19</td><td align="char" valign="top" char="." charoff="50">0.60</td><td align="char" valign="top" char="±" charoff="50">0.94±0.18</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.59</td><td align="char" valign="top" char="±" charoff="50">0.94±0.19</td><td align="char" valign="top" char="." charoff="50">0.54</td></tr><tr><td align="left" valign="top" charoff="50"> Ca (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">9.38±0.40</td><td align="char" valign="top" char="±" charoff="50">9.54±0.48</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0004</bold></td><td align="char" valign="top" char="±" charoff="50">9.50±0.46</td><td align="char" valign="top" char="." charoff="50">0.40</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.007</bold></td><td align="char" valign="top" char="±" charoff="50">9.52±0.47</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0004</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Na &lt;130 mmol/l</td><td align="center" valign="top" charoff="50">1</td><td align="center" valign="top" charoff="50">2</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.50</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">2</td><td align="char" valign="top" char="." charoff="50">1.00</td></tr><tr><td align="left" valign="top" charoff="50"> K &lt;3.0 mmol/l</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">1</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">1</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">2</td><td align="char" valign="top" char="." charoff="50">0.55</td></tr><tr><td align="left" valign="top" charoff="50"> 3.0 mmol/l ≤K &lt;3.5 mmol/l</td><td align="center" valign="top" charoff="50">5</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" char="." charoff="50">0.72</td><td align="center" valign="top" charoff="50">4</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="center" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.76</td></tr><tr><td align="left" valign="top" charoff="50"> Cre ≥1.30 mg/dl</td><td align="center" valign="top" charoff="50">4</td><td align="center" valign="top" charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.75</td><td align="center" valign="top" charoff="50">6</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.75</td><td align="center" valign="top" charoff="50">12</td><td align="char" valign="top" char="." charoff="50">0.60</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="center" valign="top" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50"><italic>Subjects with known Cre ≥1.30 (</italic>N)</td><td align="center" valign="top" charoff="50">9</td><td align="center" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="center" valign="top" charoff="50">5</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="." charoff="50">0.28</td><td align="center" valign="top" charoff="50">12</td><td align="char" valign="top" char="." charoff="50">0.48</td></tr><tr><td align="left" valign="top" charoff="50"> Change Na (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−2.0±3.0</td><td align="char" valign="top" char="±" charoff="50">−0.7±3.3</td><td align="char" valign="top" char="." charoff="50">0.42</td><td align="char" valign="top" char="±" charoff="50">−2.0±3.7</td><td align="char" valign="top" char="." charoff="50">0.54</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">−1.2±3.4</td><td align="char" valign="top" char="." charoff="50">0.58</td></tr><tr><td align="left" valign="top" charoff="50"> Change K (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−0.6±1.8</td><td align="char" valign="top" char="±" charoff="50">−0.10±0.54</td><td align="char" valign="top" char="." charoff="50">0.49</td><td align="char" valign="top" char="±" charoff="50">−0.26±0.31</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="." charoff="50">0.69</td><td align="char" valign="top" char="±" charoff="50">−0.17±0.45</td><td align="char" valign="top" char="." charoff="50">0.43</td></tr><tr><td align="left" valign="top" charoff="50"> Change Cl (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−0.8±2.3</td><td align="char" valign="top" char="±" charoff="50">−0.3±1.7</td><td align="char" valign="top" char="." charoff="50">0.64</td><td align="char" valign="top" char="±" charoff="50">−1.8±2.8</td><td align="char" valign="top" char="." charoff="50">0.27</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="±" charoff="50">−0.9±2.2</td><td align="char" valign="top" char="." charoff="50">0.92</td></tr><tr><td align="left" valign="top" charoff="50"> Change CO<sub>2</sub> (mmol/l) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−1.8±3.1</td><td align="char" valign="top" char="±" charoff="50">−2.0±2.6</td><td align="char" valign="top" char="." charoff="50">0.89</td><td align="char" valign="top" char="±" charoff="50">−3.0±1.7</td><td align="char" valign="top" char="." charoff="50">0.47</td><td align="char" valign="top" char="." charoff="50">0.44</td><td align="char" valign="top" char="±" charoff="50">−2.4±2.2</td><td align="char" valign="top" char="." charoff="50">0.61</td></tr><tr><td align="left" valign="top" charoff="50"> Change BUN (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−7.5±7.7</td><td align="char" valign="top" char="±" charoff="50">−10.9±7.5</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="char" valign="top" char="±" charoff="50">−6.4±4.2</td><td align="char" valign="top" char="." charoff="50">0.26</td><td align="char" valign="top" char="." charoff="50">0.77</td><td align="char" valign="top" char="±" charoff="50">−9.0±6.5</td><td align="char" valign="top" char="." charoff="50">0.63</td></tr><tr><td align="left" valign="top" charoff="50"> Change Cre (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−0.12±0.17</td><td align="char" valign="top" char="±" charoff="50">−0.12±0.18</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">−0.04±0.14</td><td align="char" valign="top" char="." charoff="50">0.43</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="char" valign="top" char="±" charoff="50">−0.09±0.17</td><td align="char" valign="top" char="." charoff="50">0.69</td></tr><tr><td align="left" valign="top" charoff="50"> Change Ca (mg/dl) (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">−0.01±0.41</td><td align="char" valign="top" char="±" charoff="50">0.23±0.35</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="±" charoff="50">0.44±0.61</td><td align="char" valign="top" char="." charoff="50">0.46</td><td align="char" valign="top" char="." charoff="50">0.12</td><td align="char" valign="top" char="±" charoff="50">0.3±0.5</td><td align="char" valign="top" char="." charoff="50">0.15</td></tr></tbody></table><table-wrap-foot><fn id="t5-fn1"><p>In subjects known to have a baseline creatinine ≥1.30 mg/dl, the data is shown as the change in electrolytes calculated from a baseline basic metabolic profile drawn before the bowel preparation and the basic metabolic profile drawn before the intravenous line for the colonoscopy was started. <italic>P</italic>-values in bold signify significance levels &lt;0.05.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl6"><label>Table 6</label><caption><title>Data from the questionnaire filled out by the subjects immediately before their colonoscopy</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="char" char="±"></col><col align="char" char="±"></col><col align="char" char="."></col><col align="char" char="±"></col><col align="char" char="."></col><col align="char" char="."></col><col align="char" char="±"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"> </th><th align="center" valign="top" char="±" charoff="50"><bold>1 NuLYTELY or TriLyte</bold></th><th align="center" valign="top" char="±" charoff="50"><bold>2 Gatorade/ PEG with placebo</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 2</bold></th><th align="center" valign="top" char="±" charoff="50"><bold>3 Gatorade/ PEG with 10 mg bisacodyl</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 2 vs. 3</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 3</bold></th><th align="center" valign="top" char="±" charoff="50"><bold>4 Gatorade/ PEG (both arms)</bold></th><th align="center" valign="top" char="." charoff="50"><bold><italic>P</italic>-value 1 vs. 4</bold></th></tr></thead><tbody valign="top"><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Side effects</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Nausea (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.64±0.86</td><td align="char" valign="top" char="±" charoff="50">0.41±0.72</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.04</bold></td><td align="char" valign="top" char="±" charoff="50">0.45±0.71</td><td align="char" valign="top" char="." charoff="50">0.58</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">0.43±0.72</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Vomiting (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.22±0.64</td><td align="char" valign="top" char="±" charoff="50">0.06±0.34</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">0.11±0.48</td><td align="char" valign="top" char="." charoff="50">0.23</td><td align="char" valign="top" char="." charoff="50">0.05</td><td align="char" valign="top" char="±" charoff="50">0.09±0.42</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.03</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Abdominal cramps/pain (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.46±0.70</td><td align="char" valign="top" char="±" charoff="50">0.31±0.56</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">0.46±0.60</td><td align="char" valign="top" char="." charoff="50">&lt;0.01</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">0.39±0.59</td><td align="char" valign="top" char="." charoff="50">0.20</td></tr><tr><td align="left" valign="top" charoff="50"> Bloating (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.96±0.85</td><td align="char" valign="top" char="±" charoff="50">0.74±0.71</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.005</bold></td><td align="char" valign="top" char="±" charoff="50">0.76±0.74</td><td align="char" valign="top" char="." charoff="50">0.78</td><td align="char" valign="top" char="." charoff="50">&lt;0.02</td><td align="char" valign="top" char="±" charoff="50">0.75±0.72</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.002</bold></td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Other side effects</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Headache</td><td align="char" valign="top" char="±" charoff="50">4</td><td align="char" valign="top" char="±" charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.10</td><td align="char" valign="top" char="±" charoff="50">6</td><td align="char" valign="top" char="." charoff="50">0.31</td><td align="char" valign="top" char="." charoff="50">0.52</td><td align="char" valign="top" char="±" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">0.20</td></tr><tr><td align="left" valign="top" charoff="50"> Other</td><td align="char" valign="top" char="±" charoff="50">13</td><td align="char" valign="top" char="±" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">0.17</td><td align="char" valign="top" char="±" charoff="50">9</td><td align="char" valign="top" char="." charoff="50">0.61</td><td align="char" valign="top" char="." charoff="50">0.38</td><td align="char" valign="top" char="±" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">0.18</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">% Preparation consumed (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">93.4±12.9</td><td align="char" valign="top" char="±" charoff="50">98.9±5.3</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">99.3±3.9</td><td align="char" valign="top" char="." charoff="50">0.39</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">99.1±4.6</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50">Consumed 100% of Preparation</td><td align="char" valign="top" char="±" charoff="50">137</td><td align="char" valign="top" char="±" charoff="50">188</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">191</td><td align="char" valign="top" char="." charoff="50">0.50</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">379</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50">Incomplete % consumed (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">79.0±14.9</td><td align="char" valign="top" char="±" charoff="50">82.3±13.6</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="±" charoff="50">82.6±10.2</td><td align="char" valign="top" char="." charoff="50">0.96</td><td align="char" valign="top" char="." charoff="50">0.49</td><td align="char" valign="top" char="±" charoff="50">82.4±12.0</td><td align="char" valign="top" char="." charoff="50">0.35</td></tr><tr><td align="left" valign="top" charoff="50">Called MD for advice</td><td align="char" valign="top" char="±" charoff="50">8</td><td align="char" valign="top" char="±" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">0.09</td><td align="char" valign="top" char="±" charoff="50">10</td><td align="char" valign="top" char="." charoff="50">0.22</td><td align="char" valign="top" char="." charoff="50">0.63</td><td align="char" valign="top" char="±" charoff="50">26</td><td align="char" valign="top" char="." charoff="50">0.21</td></tr><tr><td align="left" valign="top" charoff="50">Needed Fleets enemas</td><td align="char" valign="top" char="±" charoff="50">23</td><td align="char" valign="top" char="±" charoff="50">28</td><td align="char" valign="top" char="." charoff="50">0.45</td><td align="char" valign="top" char="±" charoff="50">31</td><td align="char" valign="top" char="." charoff="50">0.67</td><td align="char" valign="top" char="." charoff="50">0.24</td><td align="char" valign="top" char="±" charoff="50">59</td><td align="char" valign="top" char="." charoff="50">0.27</td></tr><tr><td align="left" valign="top" charoff="50">Number of enemas (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">1.52±0.73</td><td align="char" valign="top" char="±" charoff="50">1.54±0.69</td><td align="char" valign="top" char="." charoff="50">0.92</td><td align="char" valign="top" char="±" charoff="50">1.68±0.65</td><td align="char" valign="top" char="." charoff="50">0.43</td><td align="char" valign="top" char="." charoff="50">0.40</td><td align="char" valign="top" char="±" charoff="50">1.62±0.67</td><td align="char" valign="top" char="." charoff="50">0.56</td></tr><tr><td align="left" valign="top" charoff="50">Changed preparation due to intolerance</td><td align="char" valign="top" char="±" charoff="50">3</td><td align="char" valign="top" char="±" charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0.25</td><td align="char" valign="top" char="±" charoff="50">0</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="." charoff="50">0.25</td><td align="char" valign="top" char="±" charoff="50">0</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.04</bold></td></tr><tr><td align="left" valign="top" charoff="50">Woke up at night for bowel movement</td><td align="char" valign="top" char="±" charoff="50">104</td><td align="char" valign="top" char="±" charoff="50">127</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">129</td><td align="char" valign="top" char="." charoff="50">0.84</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.02</bold></td><td align="char" valign="top" char="±" charoff="50">256</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.005</bold></td></tr><tr><td align="left" valign="top" charoff="50">Would use the same preparation again</td><td align="char" valign="top" char="±" charoff="50">114</td><td align="char" valign="top" char="±" charoff="50">185</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">182</td><td align="char" valign="top" char="." charoff="50">0.58</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">367</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>How difficult was</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Drink liquid (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">1.33±0.97</td><td align="char" valign="top" char="±" charoff="50">0.41±0.62</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">0.45±0.70</td><td align="char" valign="top" char="." charoff="50">0.55</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">0.43±0.66</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Overall preparation (mean±s.d.)</td><td align="char" valign="top" char="±" charoff="50">0.97±0.96</td><td align="char" valign="top" char="±" charoff="50">0.38±0.63</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">0.42±0.67</td><td align="char" valign="top" char="." charoff="50">0.54</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">0.40±0.65</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td align="left" valign="top" charoff="50">Had previous colonoscopy</td><td align="char" valign="top" char="±" charoff="50">116</td><td align="char" valign="top" char="±" charoff="50">123</td><td align="char" valign="top" char="." charoff="50">0.48</td><td align="char" valign="top" char="±" charoff="50">133</td><td align="char" valign="top" char="." charoff="50">0.30</td><td align="char" valign="top" char="." charoff="50">0.08</td><td align="char" valign="top" char="±" charoff="50">256</td><td align="char" valign="top" char="." charoff="50">0.15</td></tr><tr><td align="left" valign="top" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td><td align="char" valign="top" char="±" charoff="50"> </td><td align="char" valign="top" char="." charoff="50"> </td></tr><tr><td colspan="9" align="left" valign="top" charoff="50"><italic>Previous preparation</italic></td></tr><tr><td align="left" valign="top" charoff="50"> Any 4-liter PEG preparation</td><td align="char" valign="top" char="±" charoff="50">10E:77S:9M</td><td align="char" valign="top" char="±" charoff="50">79E:16S:5M</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">85E:15S:7M</td><td align="char" valign="top" char="." charoff="50">0.84</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td><td align="char" valign="top" char="±" charoff="50">164E:31S:12M</td><td align="char" valign="top" char="." charoff="50"><bold>&lt;0.0001</bold></td></tr><tr><td align="left" valign="top" charoff="50"> Any sodium phosphate pills</td><td align="char" valign="top" char="±" charoff="50">3E:4S:4M</td><td align="char" valign="top" char="±" charoff="50">6E:4S:1M</td><td align="char" valign="top" char="." charoff="50">0.27</td><td align="char" valign="top" char="±" charoff="50">4E:5S:4M</td><td align="char" valign="top" char="." charoff="50">0.38</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">10E:9S:5M</td><td align="char" valign="top" char="." charoff="50">0.53</td></tr><tr><td align="left" valign="top" charoff="50"> Fleets phospho-soda</td><td align="char" valign="top" char="±" charoff="50">0E:1S:4M</td><td align="char" valign="top" char="±" charoff="50">1E:3S:3M</td><td align="char" valign="top" char="." charoff="50">0.56</td><td align="char" valign="top" char="±" charoff="50">2E:0S:2M</td><td align="char" valign="top" char="." charoff="50">0.18</td><td align="char" valign="top" char="." charoff="50">0.29</td><td align="char" valign="top" char="±" charoff="50">3E:3S:5M</td><td align="char" valign="top" char="." charoff="50">0.62</td></tr><tr><td align="left" valign="top" charoff="50"> Any 2-liter Gatorade/PEG</td><td align="char" valign="top" char="±" charoff="50">0E:1S:2M</td><td align="char" valign="top" char="±" charoff="50">0E:1S:1M</td><td align="char" valign="top" char="." charoff="50">1.00</td><td align="char" valign="top" char="±" charoff="50">1E:6S:2M</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="." charoff="50">0.62</td><td align="char" valign="top" char="±" charoff="50">1E:7S:3M</td><td align="char" valign="top" char="." charoff="50">0.62</td></tr></tbody></table><table-wrap-foot><fn id="t6-fn1"><p>Abbreviations: PEG, polyethylene glycol; E, easier, S, same; M, more difficult.</p></fn><fn id="t6-fn2"><p>For “previous preparation,” the study preparation was E, S, M, compared with the previous preparation. <italic>P</italic>-values in bold signify significance levels &lt;0.05.</p></fn></table-wrap-foot></table-wrap></floats-group></article>